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ABSTRACT
This dissertation presents the synthesis and characterization of several novel 
inorganic and hybrid nanoparticles, including the bio-compatible boron nanoparticles 
(BNPs) for boron neutron capture therapy (BNCT), tannic acid-templated mesoporous 
silica nanoparticles and degradable bridged silsesquioxane silica nanoparticles.
Chapter 1 provides background information of BNCT and reviews the 
development of design and synthesizing silica nanoparticles and the study of silica 
material degradability.
Chapter 2 describes the preparation and characterization of dopamine modified 
BNPs and the preliminary cell study of them. The BNPs were first produced via ball 
milling, with fatty acid on the surface to stabilize the combustible boron elements. This 
chapter will mainly focus on the ligand-exchange strategy, in which the fatty acids were 
replaced by non-toxic dopamines in a facile one-pot reaction. The dopamine-coated 
BNPs (DA-BNPs) revealed good water dispersibility and low cytotoxicity.
Chapter 3 describes the synthesis of tannic acid template mesoporous silica 
nanoparticles (TA-TEOS SiNPs) and their application to immobilize proteins. The 
monodispersed TA SiNPs with uniform pore size up to approximately 13 nm were 
produced by utilizing tannic acid as a molecular template. We studied the influence of TA 
concentration and reaction time on the morphology and pore size of the particles. 
Furthermore, the TA-TEOS particles could subsequently be modified with amine groups
allowing them to be capable of incorporating imaging ligands and other guest molecules. 
The ability of the TA-TEOS particles to store biomolecules was preliminarily assessed 
with three proteins of different charge characteristics and dimensions. The 
immobilization of malic dehydrogenase on TA-TEOS enhanced the stability of the 
enzyme at room temperature.
Chapter 4 details the synthesis of several bridged silsesquioxanes and the 
preparation of degradable hybrid SiNPs via co-condensation of bridged silsesquioxanes 
with tetraethoxysilane. In vivo studies show that the solid SiNPs accumulate in many 
organs due to the lack of degradability. The aim of our work is to address this 
shortcoming by producing novel degradable SiNPs. Bridged silsesquioxanes were used as 
the precursors of the particles, and upon cleavage of the carbamate groups when brought 
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CHAPTER 1
INTRODUCTION
1.1 Aim and significance 
Nanoparticles are defined as particles that possess sizes in the range from a few 
nanometers to a micrometer. Presently, preparation of inorganic and hybrid nanomaterials, 
such as carbon nanotubes, 1 quantum dots, 2 gold, 3 silver, 4 titanium oxide, 5 iron oxide6 
and silica nanoparticles (SiNPs) , is of great interest due to its applications for drug 
delivery, 1 , 8 bioimaging,7, 9 electrical and chemical sensors,1, 10 photonic materials, 11
1,12 13electronic device building blocks and catalysis over the past two decades. Advances 
in synthesis and fabrication enabled the production of countless new nanomaterials with 
various morphologies, and chemical and physical properties.
The advances in the development of new types of nanoparticles have led to the 
bloom of using these materials for diagnostic and therapeutic applications aimed at 
improving the treatment of diseases. Based on their small size, intrinsic chemical stability, 
multiple modification sites, and pharmacokinetic behaviors, nanoparticle systems offer 
alternatives in the fields of pharmaceuticals, drug delivery and bio-imaging for the 
treatment of various diseases. 14, 15
In the case of cancer treatment, the most universal therapeutic approaches are 
surgical resection, radio and chemotherapy. Recent advances in the cancer treatment have 
reduced the death rate; however, the number of people who suffer from cancer is still
increasing and many kinds of cancer are still considered incurable.16 Although the 
government and private companies have invested a large amount of money, there has 
been no significant breakthrough in finding a cure to this fatal disease. Surgery is very 
efficient in removing the solid isolated tumors, but this traditional cancer therapy is 
restricted by the locations of the tumors and has uncertainty regarding the completeness 
of cancerous cell removal. High risk of removing tumors from the brain or other nerve- 
and blood vessel- intensive locations by surgery is widely recognized. Radiation and 
chemical therapy are affiliated treatments for the surgical resection that address the 
remaining cancer cells or are used as alternative treatments for early stage cancer. 
However, radiation and chemicals are detrimental to the patient’s health, and some cancer 
cells become increasingly radio- and chemo-resistant. 17- 19 From this perspective, it is 
essential to develop novel therapies that are not restricted by the tumor.
Nanoparticles with a size exceeding 7 nm are promising nanomedicine agents
because they selectively accumulate in the tumor cells due to the Enhanced Permeability
20and Retention (EPR) effect, which was first described in 1986 by Maeda. For the next
decade, Maeda and his coworkers further studied this phenomenon and extensively
21- 23analyzed the different factors that contributed to it. " Since the fast growth of a cancer 
cell requires more oxygen and other nutrition compared to normal cells, when the 
aggregates reach the size of 150-200 p,m, they start developing their own blood
24supplies. However, these neovasculatures are abnormal in their architecture and 
functions. Their lack of effective lymphatic drainage 25, 26 results in the uptake of 
nanoparticles without filtration. Another attractive nanoparticle biodistribution aspect is 
that they tend to accumulate at the site of inflammation because of the enhanced vascular
2
permeability, making them potential pharmaceutical and diagnostic agents for
27inflammatory diseases. Moulari et al. reported that covalently bonding the
inflammatory bowel disease drug 5ASA to the SiNPs increases the selectivity of its
28delivery to the inflamed intestinal tissue.
SiNPs are considered potential drug carriers or bio-imaging agents, because of 
their tailored structure and active surface, and they are easy for chemical modification. 
However, the emergence of multiple biomedical applications of SiNPs is accompanied by 
recognition of the problem of bioaccumulation of the particles in multiple organs due to 
their low solubility in human serum. Considering their potential biomedical applications, 
it is required to address the shortcomings of the aforementioned nanomaterials systems 
via design and synthesis of a series of novel nanoparticles.
This dissertation is focused on synthesizing various new inorganic and hybrid 
nanoparticles and carefully exploring the attributes and properties of the particles. This 
study is beneficial as it describes new nanomaterials that have never been reported in 
literatures. The results provide information about rationally designing nanoparticles for 
biomedical applications. In addition, the particles can be used as prototypes inspiring the 
development of other new nanomaterials. In the long term, the novel nanoparticles can be 
used as bio-imaging agents or drug carriers.
In this chapter, we aim to provide background information for Boron Neutron 
Capture Therapy (BNCT), the synthesis and properties of nonporous and mesoporous 
SiNPs, and their potential biomedical applications. In subsequent chapters, we will 
describe in detail the experimental efforts in producing these particles and discuss the 
results and potential applications of the new materials.
3
1.2 Boron Neutron Capture Therapy 
The second chapter describes the preparation of water-dispersible boron 
nanoparticles (BNPs) that have the potential application as boron delivery agents for 
Boron Neutron Capture Therapy (BNCT). Herein, the background and fundamental 
knowledge of BNTC and a brief overview on the approaches to discovery and synthesis 
of boron delivery agents will be discussed.
The limitations of current cancer treatments have spurred the development of
29alternative cancer therapies. Since the discovery of neutrons, these newly discovered 
particles attracted much attention in the application to treat advanced, unresectable
30tumors, because of their highly penetrating properties and biological effectiveness. 
However, neutrons are highly toxic for both tumors and healthy tissue, causing tissue 
necrosis. The objective to selectively destroy tumor cells while maintaining the normal 
tissues unaffected led to the development of neutron capture therapy.
Neutron capture therapy is a binary therapy relying on two components: neutron 
radiation and a neutron capture agent. Since Fermi first showed that neutrons were
29readily absorbed by lithium and boron, more nuclides are found to be able to efficiently
31absorb neutrons (Table 1.1). After capturing a neutron, the nuclide is promoted to an 
unstable, exited state from which it decays through fission into another nuclide and yields
32,33high linear energy transfer (LET). Among all of the nuclides with high neutron 
capture cross-section, boron is thought to be of particular value for clinical uses. Unlike
23 5 34 35 6the radioactive 235U 34 , 35 which is highly toxic; or the nonradioactive 6Li which
compounds easily and breaks down to lithium cations36 10; B, commonly found in nature 
(20%, the other 80% is 11B), possesses a large neutron capture cross-section, can
4
5Table 1.1. Neutron capture cross-section values of multiple nuclides.
Element Cross-section Element Cross-section
6Li 942 149Sm 42000
10B 3838 151Eu 5800
22Na 32000 155Gd 6100
58Co 1900 dGd75 255000
126j 6000 235U 580
135Xe 2600000 142Pu 1 0 1 0
covalently bond with carbon, oxygen and nitrogen to form structures similar to organic 
molecules, and gives LET with effective path-length on the order of the dimension of a
10 37cell. Thus, B is the focus of the majority of neutron capture therapy (BNCT) studies.
BNCT is based on the nuclear reaction between 10B and a thermal neutron source. 
When a 10B atom captures a low energy (0.025 eV) thermal neutron, it becomes an
11 7unstable isotope B, which undergoes fission into a recoiling Li and an a particle, with a 
high linear energy transfer, which is sufficient to ionize tissue within an effective length
38 39of 5-9 pm (Figure 1.1). ’ The rationale for this therapy lies in the fact that both the low 
energy thermal neutron and boron-containing agents are harmless to human tissues until 
combined. Confining the neutron capture event within the cancer cell would cause 
damage to organelles, nucleus and cell membranes, and would effectively kill these cells 
while leaving the healthy cells unscathed—thus maximizing the treatment efficiency and 





Figure 1.1. 10B neutron capture event.
The studies of BNCT comprise two portion: The first one is the development of a 
nuclear reactor that is able to generate low energy thermal neutrons. The second one is 
the discovery of effective boron delivery agents.
The low energy neutrons obtained from the moderation of fast neutrons by heavy 
water or other media currently are limited to nuclear reactors. Nuclear reactors are 
difficult to manage and they usually cannot yield a sufficient flux of neutrons of the 
appropriate energy due to the fact that the neutrons generated from a nuclear reactor 
encompass diverse velocities. Early BNCT clinical trials failed partially because the 
nuclear reactors used were not proper for human treatment. Scientists are working on 
developing a clinically useful accelerator for BNCT to produce mono-energetic neutrons 
in the epithermal energy range (0.5-10 eV. These neutrons could penetrate deeper into the 
human body and reach the cancer cells without too much energy moderation by the 
tissues and still remain harmless to the patient’s health.
So far, limited progress has been made in the area of developing efficient boron 
delivery agents. The major challenges in the development of these agents are low toxicity, 
high tumor/brain and tumor/ blood concentration ratios (>3-4:1), boron concentrations of 
(109 boron atoms/cell), water solubility and chemical stability. Many other elements in 
the body, such as hydrogen, nitrogen and oxygen, can capture neutrons. Although they 
have much smaller neutron capture cross-sections compared to boron, their sheer 
abundances in tissues make them a considerable obstacle in consuming neutrons and 
generating background radiations. Considering the probability of the occurrence of a 
neutron capture event, approximately 1 0 9 boron atoms per cell is required to assure a 
single neutron capture event will occur.40,41 As a result, an effective boron delivery agent 
should have a high boron content to achieve this goal. Moreover, the boron delivery 
agents are required to be bio-compatible, and the accumulation ratio between cancer cells 
and blood are required to exceed 3:1.42,43 If the accumulation of boron delivery agents in 
the blood stream were comparable to that in the cancer cells, the blood vessels or other 
healthy tissues would be harmed, leading to severe damage to the patient’s health or even 
death.
Over the past 40 years, a variety of boron-containing agents have been 
synthesized, including boron porphyrins, 44,45 boron amino acids, 46 polyhedral boranes, 47
48a boronated anti-epidermal growth factor receptor, boronated nucleic acids and 
proteins, 49 DNA-binding agents50,51and monoclonal antibodies. 52 Boronophenylalanine 
(BPA) and sodium borocaptate (BSH) are the two most studied boron delivery agents that 
have been approved for clinical trials (Figure 1.2). 5 3 , 54 BPA is an amino acid 
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Figure 1.2. Boronophenylalanine (BPA, left) and sodium borocaptate (BSH, right). 
the cancer cells whose fast growth requires a larger amount of constituents compared to
overcome. BSH is one of the polyhedral boranes, generated from covalent bonding 
between boron atoms due to the unique electronic configuration of a boron valence shell. 
A single BSH molecule contains 10 boron atoms in a cage-like structure, which is 
considerably higher boron content compared to other boron containing compounds. It is 
proven that BSH can be uptaken by brain tumors, but the rationale behind this remains 
unclear. 56 In addition, the difficult synthesis of BSH derivatives hinders their further 
improvement.
Dendrimers are hyper-branched polymers, featured by the tree-like architecture 
with layers of repeat units. They hold much promise for drug delivery due to their ability 
to encapsulate guest molecules covalently and noncovalently. Yamamoto’s group 
produced dendrimers carrying multiple polyhedral carboranes with high water-solubility
57 58to increase the loading amount of boron atoms, but the difficult synthesis, expensive
the healthy cells.55 Because of the high uptake by the cancer cells, BPA is currently one 
of the standard boron delivery agents. However, the low boron content is still an issue to
cost and the demand of additional attachment of target ligands limited their applications. 
Other boron delivery agents were produced by the incorporation of boron-containing 
moieties into nucleic acids, antibodies or growth factors to achieve high selectivity. 
However, these methods either do not deliver enough boron atoms; or their high-boron 
payload results in major structural changes of the carriers, and hence affect their bio­
activities and bio-functionalities.
Most of the boron delivery agents cannot deliver a sufficient number of boron 
atoms to cancer cells, suggesting the need to develop a new boron carrier that has high 
boron payload and amenable for easy modification with targeting ligands. Recently, 
boron-containing carbon59 as well as boron nitride nanoparticles60,61 have been reported 
as potential boron delivery agents with high boron content. Boron nanoparticles (BNPs) 
in the size range of 1-45 nm are synthesized by reduction of a tribromoboron salt using 
sodium naphthelinde. However, the particles yielded from this method are highly 
combustible and require further modification with a stabilizer to prevent them from 
reacting with oxygen in the air. We developed dopamine (DA) modified water- 
dispersible boron nanoparticles (BNPs) with high boron density (ca. 10 boron atoms per
50 nm particle) as a new boron delivery agent. Moreover, with active primary amines on 
the surface, the DA-BNPs are suitable for additional modification with targeting and 
imaging ligands.
1.3 Silica nanoparticles 
Among inorganic particles for biomedical applications, silica nanoparticles 
(SiNPs) stand out due to their unique properties such as ease of synthesis, hydrophilic
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surface, the availability of surface modification, mechanical properties, and their 
relatively low cytotoxicity.
1.3.1 Silica nanoparticle synthesis
Silica nanomaterials are usually produced by sol-gel chemistry62 where silica 
precursors undergo a series of hydrolysis and condensation steps to form dimer, trimer 
and eventually particles or gels. The process of hydrolysis and condensation is catalyzed 
by either an acid or a base, which determines the morphology of the product and the 
required reaction time. The alkali conditions tend to produce solid particles while the 
acidic conditions yield gels or other soft networks of silica due to the difference in 
nucleation and particle growth under the different conditions.63
While there are a number of methods to produce SiNPs, one of the most studied 
and widely developed traditional synthesis methods is the Stober method, which was 
reported in 1968 and involves the hydrolysis and condensation of tetraethoxysilane 
(TEOS) in a mixture of ethanol, water and ammonium hydroxide with rapid stirring 
(Figure 1.3) . 64 The SiNPs produced by this method possess uniform spherical shape and 
narrow size distribution. The diameter of the SiNPs can be controlled in the range of 20 
nm to 1 pm by altering the concentrations of ammonium hydroxide, TEOS and water due 
to the fact that ammonium hydroxide increases the solubility of silica intermediates 
leading to the formation of larger particles. Because of the simple procedure of particle 
preparation and the ease of controlling the particle size, the nonporous SiNPs were 






Figure 1.3. Stober method using TEOS as the silica precursor.
1.3.2 Co-condensation for preparation of silica nanoparticles
Hybrid silica materials are typically produced by co-condensation, which usually 
involves alkali or acid catalyzed hydrolysis and condensation steps of multiple silanes. 
Most of the organosilanes with one or more organic branches cannot form SiNPs but 
result in loosely knit silica networks, due to reduced siloxane groups and steric effects of 
the organic branches. Thus, tetrasubstituted silanes such as TEOS are typically used in 
co-condensation reactions to assist in the formation of spheres. In addition, co­
condensation with TEOS provides an alternative to produce surface-modified SiNPs. The 
co-condensation of TEOS with bridged silsequixaone bis(triethoxysiyl)ethane led to the 
formation of new SiNPs with enhanced mechanical and chemical stability.65 Fluorescent 
tags and other functional moieties have been embedded into the SiNPs by co­
condensation with TEOS.66 By the encapsulation, the fluorescence tags are protected by 
the silica, which limits the interaction between the fluorescence dye and the environment, 
hence preventing the photo-bleaching and fluorescence molecule leakage. However, co­
condensation still shows several disadvantages, such as low density of function groups on 
the surface of the particles.
1.3.3 Surface modification of silica nanoparticles
Owing to the abundance of silanol groups, the surface of SiNPs is easy to 
functionalize with a variety of moieties, ranging from small organic molecules to 
polymers, to inorganic coatings.67 The modification of the SiNPs can not only offer 
functional groups but also alter the hydrophobicity, control the colloidal stability and 
other physical and chemical properties of the particles.
The surface modification of the SiNPs is usually accomplished through the 
addition of organosilane to the particle surface silanols by condensation. Moreover, 
polymer brushes can be grafted on the surface of the SiNPs by either directly attaching a 
pre-synthesized polymer on the particles, or by coupling the initiators on the surface of 
the particles then inducing the polymerization.68- 70
1.4 Mesoporous silica nanoparticles 
Mesoporous silica nanoparticles (MSNs), which combine the advantages of 
porous structure and versatile silica chemistry, have attracted much attention due to their
71 72various potential applications, including catalysis, adsorption or separation medium,
73and optical devices, since the first mesoporous silica material, MCM-41 was discovered
74,75by the researchers from Mobil Oil Company in 1992. ’ Unlike nonporous SiNPs, the 
MSNs have the advantages of high surface area and porosity making them more 
attractive for guest molecule incorporation. During the past decade, numerous strategies 
were developed to produce a variety of mesoporous silica materials with diverse 
morphologies, pore sizes and pore arrangements.76 Most of them were achieved by using 
surfactants as pore-forming agents, such as cetytrimethylammonium bromide (CTAB), 
triblock copolymer pluronic-123 (PEO20PPO70PEO20) . 77
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1.4.1 Mechanism of mesoporous silica materials formation
The formation of mesoporous silica is generally managed by the interactions 
between surfactant micelles and silica species such as electrostatic, hydrogen-bonding
78 79and Van der Waals interactions. ’ The geometry of the mesophase is known to be
80mainly determined by surfactant micelle morphology. However, the mechanisms for 
cationic, anionic and non-ionic surfactants as pore-directing agents are different from 
each other.
The mechanism of cationic surfactant template MSNs was postulated by Beck et 
al., where the silica-surfactant self-assembly occurs simultaneously with condensation of
75the silica precursors. In the case of MCM-41, which was produced with cationic CTAB 
in alkaline condition, there are two possible mechanistic pathways. One suggested that 
when the surfactant concentration reaches the critical micelle concentration, the 
surfactant will self-assemble into micelles; and then the hydrophobic silica precursors 
will condensate on the polar side of the micelles and form into silica walls around the 
micelles (Figure 1.4). The other possible pathway suggests that supramolecular structure 
is formed with the mutual interactions between the silica species and surfactants by 
electrostatic interaction.
The mechanism of non-ionic triblock copolymer templated SBA-15 involves a 
combination of electrostatic and hydrogen-bonding interactions. Under the very strong 
acidic condition, the protonated silica species are positively charged and self-assemble 
with copolymers by electrostatic interaction. Moreover, the abundance of hydrogen 
bonding between the silica species and the hydrophilic blocks allows for the formation of 
silica walls around the supermolecular structure.
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Figure 1.4. Mechanism for formation of mesoporous structure of MCM-41. 78
1.4.2 Synthetic routes to mesoporous silica materials
Over the past decade, surfactant-templated synthetic methods for numerous 
mesoporous materials that possess different geometry, porosity and chemical
compositions have been developed. The particle size and morphology can be controlled
81 82from sphere, to rod, to worm-like structures by changing the molar ratio of silica
83 84 85precursors and surfactants, pH, ’ addition of co-solvents or organic swelling agents, 
and introduction of organoalkoxysilane precursors during the co-condensation 
reaction.86, 87 The diameter, morphology and arrangement of the pores are determined by 
the surfactant type and concentration, and reaction temperature.
The synthesis of first and most extensively studied mesoporous silica materials,
74,75MCM-41, was published by the scientists in Mobil Oil Company in 1992. , With the 
cationic surfactant of cetyltrimethylammonium bromide (CTAB) as liquid crystal 
template, tetraethyl orthosilicate (TEOS) or sodium metasilicate (Na2SiO3) as the silica 
precursor, and alkali as catalyst, MSNs with an ordered arrangement of parallel uniform 
two-dimensional (2D) hexagonal close-packed mesopores were synthesized and named
as MCM-41. The shape of the MCM-41 particles depends on the CTAB concentration, 
stirring rates and solution acidity. The aspect ratio can be tuned from 1-8 by increasing 
the CTAB concentration, and the particle size increases with ammonium concentration. 
The CTAB is removed by either calcination or solvent extraction (e.g. with HCl ethanol 
solution). Most of the MCM-41 materials were irregularly shaped. The Lin group made 
significant progress in controlling the MCM-41 shape while maintaining the highly
porous structure by carefully manipulating the interaction between the CTAB and silica
88species. The smallest MCM-41 nanoparticles were produced by the Mou group. They
89successfully prepared spherical MCM-41 naoparticles with a size down to 20 nm.
SBA-15 is one of the most studied mesoporous silica materials due to the large 
tunable pore (7-50 nm) and good hydrothermal stability. The synthesis of SBA-15 is first 
reported by the Stucky group in 1998.90 The hexagonal p6 mm, two-dimensional channel 
structure was attained by utilizing nonionic triblock coplolymer as template to direct the 
organization of polymerizing silica species in a strong acidic condition (pH < 1) at the 
reaction temperatures between 35° and 80 °C. The silica species are positively charged 
under these conditions because the pH value is below the isoelectric point of silica (pH = 
2), thus they undergo cooperative self-assembly with the triblock copolymers. The 
amphiphilic triblock copolymer used in SBA-15 synthesis is poly(alkylene oxide) 
triblock copolymers such as poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene 
oxide) (PEO-PPO-PEO). The pore size and structure of SBA-15 can be adjusted by using 
poly(alkylene oxide) triblock copolymers with different mass and EO:PO block size 
ratios; by varying the reaction temperature and time; or by adding cosolvents such as 
1,3,5-trimethylbenzene (TMB).
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Compared to MCM-41 particles, SBA-15 has the advantages of large tunable pore 
size and thicker silica walls. Despite these advantages, molecular diffusion through the 
lengthy channel as well as the difficulty controlling the particle size of SBA-15 below 
2 0 0  nm are the main concerns while preparing these materials for bio-medical 
applications.
1.4.3 Biomedical applications of mesoporous silica materials
Because of the large internal surface areas and ability to protect the sensitive 
cargos from the external environment, the MSNs are considered as ideal materials for 
pharmaceutical encapsulation, imaging and diagnostic labelling and other biomedical 
applications. 91 Silica walls not only reduce the interaction of the cargos with the 
environment but also provide surfaces for multiple modifications. The encapsulation of 
hydrophobic and toxic pharmaceuticals is another advantage of mesoporous silica 
materials.92
The encapsulation can be easily accomplished by immersing the MSNs into a 
solution of the guest molecules which enter the pores driven by diffusion, capillary forces 
and noncovalent interactions such as electrostatic interaction, hydrogen bonding and Van 
der Waals forces. For the MSNs modified with functional groups, the guest molecules are 
also able to be immobilized via covalent bonds. The pore opening size and pore 
morphology affect the efficiency and rate of encapsulation.
After the loading of the guest molecules, a cap or plug can seal the pore and the 
guest molecules are trapped within the particles until the removal of the caps. The caps 
can be designed to respond to external stimuli, such as acidity or temperature.93,94 The 
variations in physical and chemical properties play an important role in determining the
16
compatibility of MSNs with biological systems. 95, 96 Recent studies show that the 
morphology of the nanoparticles influence their circulation half-life and other
97pharmacokinetic parameters. The biocompatibility of MSNs with diameter of 150nm, 
800nm and 4p,m and pore sizes of 3 nm, 7 nm and 16nm has been examined in animal 
models. Slowing et al. reported the uptake of mesoporous silica nanoparticles by cervical
98cancer cells was improved by surface functionalization with cationic moieties.
1.5 Degradation of silica nanoparticles 
Silica-based nanomaterials have many potential bio-medical applications 
including drug delivery systems99 and bio-imaging probes. 100 However, reports of long­
term accumulation of silica nanomaterial in various organs with adverse health 
effects,101, 102 question the potential bio-application of these materials. 103 Therefore the 
study of degradability of the silica materials in aqueous medium is critical. 104
The solubility of silica in water is very low and the solubility is highly dependent 
on the temperature and pH. The bulk amorphous silica powder and micron-sized colloidal 
SiNPs show similar water solubility of approximately 0.01% due to the identical 
fundamental structure of amorphous silica in these materials. 105 It hydrolyzes in water to 
form monosilicic or polysilicic acid. Since the majority of the silicic acid degraded from 
silica is monosilicic acid, most of the degradation studies of the silica are based on the 
data of the monosilicic acid concentration. Monosilicic acid, unlike its polymeric form, is 
considered nontoxic (that does not show cell toxicity in up to 3 mM concentrations) and 
can transfer through the tissues, enter blood vessels and eventually be excreted with
17
The dissolution of silica depends on the equilibrium between the solid silica and 
monosilicic acid. Therefore, the low concentration promotes the degradation in order to 
reach the saturation of the monosilicic acid. It is known that the solubility of silica 
significantly increases under the basic conditions. One explanation suggested by 
Alexander et al. 105 is that the presence of H3 SiO4- ions, which are produced from 
monosilicic acid under the basic solution, impels the further silica dissolution due to the 
continuous consuming of the monosilicic acids. However, the concentration of 
monosilicic acids is not affected by pH value.
Si(OH)4 + OH- = H3 SiO4- +H2O 
The rate at which SiNPs degrade depends on a number of factors including 
composition, surface area, pore structure and concentration of the silica particles. The 
surface area plays an important role in the degradation of silica. An increase in the 
surface area of nanoparticles leads to increased degradability of colloidal SiNPs because 
of the greater contact with water at the interfaces. The degradation rate of MSNs is higher 
than that of nonporous silica nanoparticles with the same diameters because of the 
presence of mesopores and thus larger surface area. Experiments also showed that 
smaller, nonporous SiNPs degrade faster than the larger, nonporous SiNPs; colloidal 
SiNPs degrade faster than the aggregates; and the MSNs with different diameter but same
107surface area show the same degree of dissolution due to the effect of surface area.
The surface ligands also affect the degradation of the particles. The solvent-
extracted, surfactant-templated MSNs dissolve faster compared to the calcinated MSNs
108due to the higher surface coverage with silano groups. The modification of poly
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ethylene glycols on the surface of the MSNs suppresses the degradability of the silica in 
SBF109 and PBS. 110
The nonporous SiNPs possess a mild degradation process. The degradation 
pathway includes initial surface bust erosion followed by a slow degradation of the bulk 
silica. The speed of silica degradation sharply declined after 2-7 days, then gradually 
approach zero. 104
Yamada group reported that the MSNs partially retain the mesoporous structure, 
even at 70% degradation. They suggest that the degradation proceeds on the external and 
inner surfaces of particles heterogeneously due to different diffusion rates of water on the
107external surface and in the pores. In addition, the pore structure also affects the 
degradation speed of the MSNs due to the different diffusion rates. For example, the 
MSNs with disordered 3D pore structure degrade slower than the MSNs with ordered 2D
channels. 111
Studies of the degradation of silica nanomaterials in simulated human serum are 
important for the applications of the materials. It is found that the metal ions in the
112 113solution affect the degradation behavior of silica. The degradation behavior of 
MCM-41 in SBF involves a fast degradation stage in the first several hours, and a
decelerated degradation blocked by the formation of calcium and magnesium silicate
108layer. The Sanchez group reported that the degradation of mesoporous silica films in 
PBS proceeds at high rate in the initial hours. 114 The degradation simultaneously 
proceeds from the external as well as the inner surfaces of MSNs, and the mesostructure 
and morphology are partly retained even after more than half of the MSNs are degraded.
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Researchers also designed and synthesized novel SiNPs that are considered bio­
degradable. Metal cations were doped into the silica networks to alter the composition of 
the silica shells. 115, 116 Removing the cations from the silica structure by diffusion and 
chelation results in the destabilization of the structure. Bio-degradable polymers such as
117poly(L-lactic acid) were incorporated into the silica matrix. Hydrolysis of the polymers 
led to the degradation of the silica material. Our approach to silica biodegradability is 
entirely different; our approach uses organosilane precursors with electron-withdrawing 
groups to destabilize the silica structure, as described in Chapter 4.
1.6 Thesis overview
This thesis will focus on the design and preparation of novel inorganic and 
organic/inorganic hybrid nanoparticles. The motivation and significance of these studies 
will be explained, and the potential applications of the new materials will be discussed. 
The first project deals with producing bio-compatible boron nanoparticles for Boron 
Neutron Capture Therapy (BNCT). In an effort to achieve biocompatibility, the 
hydrophobic boron nanoparticles obtained from ball milling underwent a ligand exchange 
process to replace the surface ligands with dopamine, to impart good water-dispersibility 
while also providing active amine groups for further functionalization of the particles 
with imaging or targeting ligands. In the other projects, silica nanoparticles (SiNPs) with 
novel structures were designed and synthesized. The synthesis of large-pore mesoporous 
SiNPs using tannic acid (TA) as a pore-directing template, and their application to 
immobilize proteins, were described in the third chapter. To achieve degradable silica 
nanoparticles, a silsesquioxane with a cleavable bridge was synthesized. Co-condensation
20
of tetraethoxysilane (TEOS) with the bridged silsesquioxane provided interesting SiNPs, 
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Boron neutron capture therapy (BNCT) of cancer is based on the nuclear reaction 
between 10B and slow neutrons, first forming an unstable isotope, 11B, which undergoes 
fission into high linear energy transfer (LET) Li nuclei and alpha particles. Low energy 
(0.025 eV) neutrons are sufficient to initiate the neutron capture reaction; this energy is 
below the threshold of the energy that causes damages to the tissue components. The 
energy generated from the neutron capture reaction is several times higher than the 
energy of the initial neutron beam, and can eradicate tumor cells. Moreover, because the 
high LET particles have limited biologically-effective path lengths in tissue (5-9 pm) , 1 
the destructive effects of these high-energy particles are limited to or near boron- 
containing cells.
The major challenges in the development of boron delivery agents are achieving 
high boron concentrations of 109 10B/cell, high tumor/brain and tumor/blood 
concentration ratios (>3-4:1) , 2- 4 low toxicity, 5 water solubility and chemical stability.6 
Over the past 40 years, a variety of boron-containing agents have been designed and
7, 8 9 10synthesized, including boron porphyrins, boron amino acids, polyhedral boranes, a
11 12 , 13boronated anti-epidermal growth factor receptor, DNA-binding agents and
monoclonal antibodies. 14 Among those, boronophenylalanine (BPA) and sodium
borocaptate (BSH) are the only two boron delivery agents that have been used 
clinically. 15, 16 However, most of the boron delivery agents cannot deliver a sufficient
17number of boron atoms to the cancer cells. Recently, boron-containing carbon and
18 19, 20silver nanoparticles, as well as boron nitride nanoparticles have been reported as 
potential boron delivery agents with high boron content. In this respect, pure boron 
nanoparticles (BNPs) should be superior boron delivery agents with even higher boron 
density (ca. 10 boron atoms per 50 nm particle), compared to other boron delivery 
agents. 21
The goal of this research project is to produce new boron delivery agents. 
Recently, a practical surfactant-assisted ball milling method to produce air-stable BNPs
22,23on a large scale was reported. However, these particles are hydrophobic due to the 
surface fatty acid molecules, and are not suitable for biomedical applications. This 
chapter describes the preparation of water dispersible BNPs with surface amine 
functionality by exchanging the surface fatty acid ligands with dopamines (DA). 
Characterization of these nanoparticles was performed by transmission electron 
microscopy (TEM), X-ray photoelectron spectroscopy (XPS), thermogravimetric analysis 
(TGA), mass spectrometry, and fluorescence spectroscopy. The resulting BNPs were 
functionalized with fluorescence tags and poly ethylene glycol (PEG). The study also 
includes the exploration of the chemical modification of the amine-modified particles and 
initial biocompatibility studies, as well as the cellular uptake of the DA-BNPs performed 
on cultured murine macrophage cells.
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2.2 Experimental section
2.2.1 Chemicals and instruments
Elemental boron powder (Sigma-Aldrich), Undecylenic acid (UND acid, Sigma- 
Aldrich), Dopamine hydrochloride (Sigma-Aldrich), anhydrous sodium carbonate 
(Sigma-Aldrich), O-phthaldialdehyde (OP A, Sigma-Aldrich), P-mercaptoethanol (BME, 
Sigma-Aldrich), oleic acid (OA, Sigma-Aldrich), L-ascorbic acid (Vitamin C, Sigma- 
Aldrich), dansyl chloride (Sigma-Aldrich), fluorescein isothiocyanate (FITC, Sigma- 
Aldrich), Rhodamine B isothiocyanate (Sigma-Aldrich) were purchased from commercial 
suppliers and used without further purification. N,N-dimethylformamide (DMF, 
Mallinckrodt) was dried by anhydrous magnesium sulfate. Hexane (technical grade, 
Sigma-Aldrich), chloroform (reagent grade, MACRON), methanol (ACS Reagent, Fisher 
Scientific) and ethanol (200 proof, ACS-grade, Pharmaco-Aaper) were used as solvents 
without further purification. Millipore water (18 MQ • cm) used in all experiments was 
obtained from a Barnstead “E-pure” water purification system.
The ball-milling was done in a Spex-CertiPrep 8000M mixer using a tungsten 
carbide jar and tungsten milling balls. The transmission electron microscopy (TEM) 
images were recorded with a FEI Philips Techna T-12 microscope operating at 120 kV. 
Scanning electron microscopy (SEM, FEI Nova Nano 600, Hillsboro, OR), dynamic light 
scattering (DLS, A Particle Sizing Systems NICOMP 380, Santa Barbara, CA),were used 
to analyze the morphology and size distribution of BNPs. Zeta-potential measurements 
were carried out in water using a NICOMP 380 ZLS Zeta Potential/Particle Sizer 
(PSS • NICOMP Particle Sizing Systems). Fluorescence spectra were recorded using a 
RF-1501 Spectrofluorophotometer (SHIMADZU). FT-IR spectrometer (Thermo
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Scientific Nicolet 8700 model) was used for surface functional group detection. The 
sample particles were suspended in solutions then several drops were added to the sample 
window and dried in the air. The spectra were recorded from 400 to 4000 cm-1. 
Thermogravimetric analysis (TA Instruments TGA 2050 or TA Instruments TGA 2950) 
was performed either in nitrogen or argon atmosphere. About 10 mg of the sample was 
measured on an open platinum pan by TGA. X-Ray photoelectron spectroscopy (XPS, 
Kratos Axis Ultra instrument, Chestnut Ridge, NY), and Mass spectrometry (Waters ESI- 
TQD) were employed to analyze the surface of the BNPs. A Branson 1510 sonicator was 
used for all sonications. A Clay Adams Compact II Centrifuge (3200 rpm, Becton 
Dickinson) and ultracentrifuge Sorvall RC5B Plus (15000 rpm on a SA-600 rotor) were 
used for all centrifugations.
2.2.2 Preparation of air-stable boron nanoparticles
Micro-scale elemental boron powder (2 g) was grinded in a Spex-CertiPrep 
8000M mixer mill with tungsten carbide or stainless steel balls in a tungsten carbide 
milling jar at an 80:1 charge ratio (ball to powder ratio). To protect boron surfaces from 
oxidation, 1 mL of undecylenic acid or oleic acid was added to the boron powder in 15 
mL of hexane prior to milling. Since the ratio of the solvent and surfactants are crucial in
24 , 25optimizing the milling process, the above milling condition was optimized after 
several trials. During the first 6  h of grinding time, the boron powder was broken down 
rapidly. After 6  h, the diameters of the BNPs seemed to reach a minimum limit of 30 nm. 
Samples milled for 7 to 11 h did not show a significant size discrepancy. Thus, all 
nanoparticles used in this work were prepared by 7 h of milling. The resulting 
undecylenic acid-coated boron nanoparticles (UND-BNPs) and oleic acid coated BNPs
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(OA-BNPs) were washed by methanol to remove excess fatty acid and redispersed in 
hexane. SEM, DLS and TEM were used to analyze morphology and size distribution of 
BNPs.
2.2.3 Ligand exchange reaction
The ligand exchange reaction of fatty acids by rigid diol molecules on the BNPs 
was proven to be a versatile method. In this chapter, we produced DA-UND-B, DA-OA- 
B and ascorbic acid-UND-B by the same procedure. A typical ligand exchange reaction is 
described below. Dopamine hydrochloride was used to substitute the fatty acids on the 
surface of boron nanoparticles. 26 The ligand exchange reaction took place in a 2:1 
mixture of chloroform and N,N-dimethylformamide (DMF) with approximately 10 mg of 
anhydrous sodium carbonate and 8 mg of dopamine hydrochloride. The solution was 
stirred for a few minutes to homogenize. After mixing the solvents and dopamine 
hydrochloride, approximately 0.13 g of dry UND-BNPs (1.7*1015 BNPs) were added to 
the solution and allowed to react under the nitrogen atmosphere overnight. Hexane was 
then added to the suspension to precipitate the nanoparticles, while the UND acid 
remained in hexane. After all the particles settled to the bottom, the hexane and the UND 
acid were removed. The dopamine-coated boron nanoparticles (DA-BNPs) were 
redispersed in water leading to a solution with a brownish or reddish color. Larger BNPs 
and aggregates settled on the bottom of the vials after 30 min, but the smaller particles 
remained suspended in water for over a month. Smaller BNPs were separated by 
centrifugation (3000 rpm, 10 min), and had a size distribution in the range of 30-40 nm 
as measured by DLS, TEM and SEM. X-ray photoelectron spectroscopy,
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Thermogravimetric Analyses, Mass spectrometry and proton nuclear magnetic resonance 
(1H NMR, Unity 300) were employed to analyze the surface of these DA-BNPs.
2.2.4 Purification of boron nanoparticles
After the ligand exchange process, the DA-BNPs were purified to remove any 
free dopamine by either Micro-centrifuge Filters with 5K MWCO cutoff (Sigma), or 
Slide-A-Lyzer Dialysis Cassettes with 3.5K MWCO cutoff (Thermal Scientific). 
Centrifugation at 12,000 rpm for 10 min was employed to centrifuge the samples 4-5 
times. The dialysis cassettes were placed in 400 mL beakers filled with water for 12 h 
(replacing water every 4 h).
2.2.5 Mass spectrometry analysis of the particles
The dopamine-modified BNPs (17.6 mg, containing 2.53 x 1 0 14 BNPs), purified 
by dialysis, were placed in 3.2 mL aqueous solution of hydrochloric acid (pH = 2) to 
remove the dopamine from the surface of the particles. The particles were allowed to 
remain in the acidic solution for 72 h to ensure the complete removal of the dopamine. 
The solution was then placed in the centrifuge to remove the solids, and the supernatant 
was collected. A control sample was also prepared in the same fashion but with neutral 
aqueous solution. Mass spectrometry (Waters ESI-TQD) was then used to determine if 
dopamine was present in the supernatants. A standard addition analysis was then 
performed for the supernatant prepared under the acidic conditions to determine the 
amount of dopamine on the surface of the DA-BNPs. Aliquots, ranging from 50 to 400 
mL, of a 116 ppm standard dopamine solution were added to 200 mL of the supernatant 
and diluted to a total volume of 1 mL. The dopamine intensities were recorded with 
different added amounts of dopamine and plotted to find the concentration of dopamine
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in the supernatant. The concentration of dopamine in the unknown was found by solving 
for Y = 0 of the linear equation and accounting for the dilution. By plotting intensity vs. 
dopamine concentration in ppm (Y = 6.44 x 104 X + 4.42 x 106), we found that the 
supernatant contained 1.10 mg of dopamine (4.32 x 1 0  molecules). This information was 
used to calculate the number of dopamine molecules on the surface of DA-BNPs 
assuming 40 nm diameter particles.
2.2.6 Attachment of fluorescent tags
The reaction of O-phthaldialdehyde (OPA) with the primary amine containing
27BNPs in the presence of P-mercaptoethanol (BME) took place in water (Figure 2.1). 
The OPA solution was made by dissolving 40 mg of OPA in 1 mL of methanol. The 
solution was then added to 1.2 mL of the purified DA-BNP solution followed by the 
addition of 200 pL of BME and diluted with 48 mL of water. The fluorescence was 
measured after 15 min reaction time. The resulting particles had blue fluorescence with 
maximum emission peak at 455 nm.
2.2.7 PEGylation of boron nanoparticles
Polyethylene glycol (PEG) is well-known as a biocompatible ligand that allows a 
slowed clearance of the nanoparticles from the blood and makes for a longer acting
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Figure 2.1. Fluorescent tag attachment: OPA reacts with primary amine on the surface 
of BNPs.
28 29medicinal effect. ’ 10 mg PEG (n) monomethyl ether, mono (succinimidyl succinate) 
ester (2000 Da) were added into DA- BNPs solution and reacted overnight (Figure 2.2). 
The resulting DA-PEG covered boron nanoparticles (DA-PEG -BNPs) were analyzed by 
TGA.
2.2.8. Prelim inary cell study
Murine macrophage cell line RAW264.7 was obtained from ATCC (Manassas, 
VA) and was maintained in Dulbecco’s Modified Eagle’s medium (ATCC) supplemented 
with 10% fetal bovine serum (HyClone, Logan, UT). Cells were cultured at 37 °C in 5% 
CO2 and 95% humidified air, and kept in logarithmic phase of growth throughout all 
experiments.
For morphological study, RAW264.7 cells were plated at the initial density 
20,000 cells/cm , and 24 h after plating, were exposed to 10% (v/v) of the original 
concentration of BNPs. After 72 h incubation, cell morphology was assessed with a 
Nikon Diaphot-300 phase-contrast microscope (Nikon, Melville, NY). Images were 
captured using Nikon DXM1200C digital camera and ACT-1C 1.01 software.
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Figure 2.2. The reaction between dopamine coated boron nanoparticles and PEG.
4 mg of DA-OA-B was redisperesed in 3 mL ethanol via sonication. 13.4 mg of 
rhodamin B isothiocyanate or 22.8 mg fluorescein isothiocyanate (FITC) was added into 
the BNP suspension and followed by 5 h reaction with continuous stirring. The 
purification was done through a dialysis process against water. The resulting dye labeled 
DA-OA-BNPs incubated with RAW264.7 cells for 6  h.
2.3 Results and discussion
2.3.1 P reparation and characterization of dopamine-modified 
boron nanoparticles
The surfactant-assisted ball milling method was originally designed to produce
22,23oxide-free, hydrophobic BNPs stabilized by fatty acid ligands, e.g., oleic acid (OA). ’ 
Such particles are not suitable for bio-applications because of their hydrophobic nature. 
To change their surface properties, we considered ligands with high boron-affinity, such
30 32as diols, glycerols, and other molecules with more than one hydroxyl group. - 
However, moieties containing flexible linkers between hydroxyl groups might result in 
binding to other BNPs, leading to severe coalescence. On the other hand, molecules with 
two hydroxyl groups attached to a rigid unit should be able to bind to the same boron 
particle simultaneously without causing particle aggregation. Dopamine is known to form 
bidentate bonds to metal oxides, such as iron oxide, and to replace oleic acid from the
30,31surface of iron oxide nanoparticles. ’ Thus, we decided to investigate the possibility of 
using dopamine in a ligand-exchange reaction with fatty acid-modified boron 
nanoparticles (Figure 2.3). With the amine group, dopamine should make the BNPs water 
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Figure 2.3. The molecule structures of dopamine, undecylenic acid and the scheme of 
ligand exchange on the BNPs.
In order to perform the ligand exchange, we treated UND-BNPs with dopamine 
hydrochloride in a 2:1 mixture of chloroform and DMF at room temperature under the 
nitrogen atmosphere. The resulting nanoparticles would not redisperse in hexane, but 
could be dispersed in water (Figure 2.4), indicating that the surface of these particles 
became hydrophilic after the ligand exchange.
The size distribution and surface morphology were obtained by TEM. TEM is a 
standard imaging technique to study the morphology and particle size distribution for
33nanoparticles depending on the penetration of electron beam at high voltage. Upon 
solvent evaporation during the TEM sample preparation, the particles became aggregated 
and most of the TEM images were obtained for agglomerates of the particles. 34 Since 
boron has a low electron density, it was difficult to find separated BNPs under the scope. 
As evident from TEM image analysis, BNPs were produced with diverse morphology 
due to the mechanical ball milling. However, irregularly shaped BNPs with the average 
diameter of 33 nm still could be identified (Figure 2.5).
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Figure 2.4. DA-UND-B (left) suspended in water and UND- B (right) settled on the 
bottom of the vial in water.
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Figure 2.5. Representative TEM (left) and SEM (right) images of DA-BNPs.
The size distribution and surface morphology were also observed by SEM. DA- 
BNP samples for SEM were prepared by drying a drop of the BNP solution on a copper 
grid. Based on SEM images (Figure 2.5), the average diameter of dopamine-covered 
boron nanoparticles was about 40 nm.
Both of the TEM and SEM require the sample in a solid, dry state and do not 
provide hydrodynamic size of the nanoparticles in solution. Therefore, the electron 
microscopy techniques are usually combined with dynamic light scattering (DLS) to 
further investigate the size profile of the particles. The particles were suspended in water, 
and the DLS measurements were performed at room temperature and a scattering angle 
of 90°. Since these particles were produced by the milling machine, they were not 
uniform and had a broad size distribution. Even after the small particles were purified by 
centrifugation, they showed a broad major peak (up to 99.8%) ranging from 11-70 nm 
with an average diameter of 38 nm by DLS (Figure 2.6). The second peak which was 
around 150 nm was due to the remaining large particles or aggregation of the particles.
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Figure 2.6. Distribution of DA-UND-B according to DLS.
The surface characteristics have a profound influence on the interaction of the 
BNPs with water or other mediums, controlling the dispersibility of the particles and their 
cytotoxicity. The DA-modified nanoparticles were studied by XPS to examine their 
surface composition. An intense peak of chloride interfering with boron peak was 
detected for the unpurified sample while purified samples did not possess this peak. The 
chloride originated from dopamine chloride. Therefore, its disappearance in purified 
samples demonstrated the success of the purification process by dialysis. Most 
importantly, the presence of an N 1s peak (Figure 2.7) confirmed the presence of 
dopamine on the surface of DA-BNPs.
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Figure 2.7. XPS data for N 1s of DA-BNP particles.
As seen in the B 1s photoelectron spectra of the purified, dried DA-BNP sample 
(Figure 2.8), the DA-BNPs possess two peaks: the most intense one for elemental boron
35at 189 eV; and the second peak at 193 eV, which can be identified as the BxOy peak. 
After analyzing as-prepared samples, they were sputtered with argon. Longer sputtering 
times led to a higher percentage of elemental boron on the surface; and after 6  minutes of 
argon sputtering, the BxOy peak decreased significantly, suggesting that the majority of 
the oxide was due to physisorbed oxygen. The oxide formation may originate from UND- 
BNPs whose surfaces were not fully covered by UND acid. Regardless of the boron
oxide presence, DA-BNPs can generate high linear transfer energy particles, and thus,
20can be used as a BNCT agent.
Thermogravimetric data for dopamine-modified BNPs were collected to further 
study the surface coverage of these nanoparticles. TGA measurements were first 
performed under the nitrogen atmosphere to avoid oxidation of boron in the air.
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Figure 2.8. 1s XPS pattern of DA-BNP nanoparticles as a function of sputtering time.
However, a gradual weight increase was observed above 600 °C. This may be the result 
of boron reacting with nitrogen at elevated temperature. It is known that this reaction 
starts at 320 °C, accelerates at 470 °C, and ignition occurs between 650 and 800 °C. 36 
Thus, the observed weight increase might have been caused by the formation of boron 
nitride. To avoid this problem, TGA analysis was performed under the argon atmosphere. 
Under these conditions, TGA showed a smaller, but visible weight increase above 600 °C 
as well (Figure 2.9), possibly due to the presence of impurities in argon. The TGA of 
DA-BNPs showed the total %w loss of 6.4% at ca. 400 °C, corresponding to four 
molecules of dopamine per nm of the nanoparticle surface.For comparison, we 
performed TGA analysis of UND-BNPs. The weight loss of UND-BNPs occurred at ca. 
380 °C in one step; the %weight loss was 3.9%, corresponding to two UND molecules 
per nm of the nanoparticle surface. The lower number of UNDs on the nanoparticle 
surface may result from the larger size of these molecules. The equation of surface 
coverage calculation is listed here:
where nngand is the number of the ligands, and SA is the surface area (nm ), we assumed
that the BNPs were spherical and had a uniform size of 40 nm; the surface area equates to
2 2  4nr , SAsp is the surface area of a single particle (nm ), WL is the weight loss percentage,
WR is the weight remaining, Wsp is the weight of single particle (g) calculated under the
assumption that the particles consist of pure elemental boron.
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Figure 2.9. TGA plots for UND-BNPs (dashed line) and DA-BNPs (solid line) under 
nitrogen.
Mass spectrometry was used to analyze solutions obtained from treating DA- 
BNPs under both neutral and acidic conditions. When the acidic sample was analyzed, a 
dopamine peak was found with a m/z of 154 (Figure 2.10 upper). However, when the 
neutral sample was analyzed, no dopamine peak was observed (Figure 2.10 lower). This 
demonstrates that the dopamine on BNPs are stable in water. Next, we performed a 
standard addition analysis to find the amount of dopamine present on the BNPs. We 
added different concentrations of dopamine to the sample and plotted dopamine peak 
intensity vs. added concentrations of dopamine. Using this method, we calculated that the 
dopamine coverage of the BNPs was 3.8 DA molecules per nm , which is similar to the 
value determined by TGA.
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Figure 2.10. ESI-MS spectra of aqueous solutions obtained from DA-BNPs under 
(upper) acidic and (lower) neutral conditions.
We also attempted to use 1H NMR in D2O to study the surface information of 
BNPs. Microcentrifuge filters (5K DA) were used to replace water into D2O and remove 
the free DA. However, no NMR signal was detected. This was probably because the 
rigidity of the surface dopamine structure did not allow for bond rotation, which 
indirectly supported the idea of dopamine attaching to BNP surface with both of the 
hydroxyl groups. There was also the possibility that the BNPs were too bulky, or the 
amount of the dopamine was not enough to be detected by 1H NMR.
2.3.2 Surface modification of DA-BNPs
Fluorescence could be a useful method of locating the BNPs in vitro. With this in 
mind, and to chemically confirm the presence of dopamine on the surface of DA-BNPs, 
we treated them with an amine-reactive fluorescent dye. The reaction of O- 
phthaldialdehyde (OPA) with primary amines in the presence of P-mercaptoethanol
27(BME) takes place in water, and the resulting species possess blue fluorescence with 
excitation wavelength of 340 nm and emission wavelength at 450 nm.
Thus, we treated DA-BNPs with OPA in water (Figure 2.1). After the 
purification, the treated particles showed blue fluorescence under the UV light. In order 
to demonstrate the selectivity of the OPA surface modification, we examined the 
fluorescence of the following samples: (1) OPA + BME; (2) DA-BNP; (3) DA-BNP + 
OPA + BME; (4) UND-BNP; (5) UND-BNP + OPA + BME (Figure 2.11). All 
fluorescence measurements were performed using an excitation wavelength at 325 nm 
and the emission wavelength in the range from 350 to 600 nm. Figure 2.11 shows five 
fluorescence spectra, the reference samples of DA and OPA, and surface-modified BNPs. 
Only the DA-BNPs treated with OPA revealed a fluorescence emission peak at ~455 nm, 
while the other samples showed no significant emission. This showed that the primary 
amines on the surface of DA-BNPs reacted with OPA, confirming that dopamine 
moieties were indeed attached to the BNP surface.
PEGylation, the covalent attachment of PEG, is a proven method to provide 
nanoparticles with better biocompatibility, resistance to the plasma coadsorption, and 
longer circulation and body retention. Thus, the DA-UND-BNPs were modified with 




Figure 2.11. Fluorescence spectra for OPA (black), DA-BNPs (red), UND-BNPs 
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Figure 2.12. TGA plots of UND-BNPs, DA-BNPs and DA-PEG-BNPs
TGA of PEG-coated BNPs revealed a significant weight loss (83%), starting from 200 °C 
to 400 °C, attributed to the decomposition of PEG. Calculated from the weight loss 
percentage, the surface coverage of UND acid, DA, DA-PEG, were 2, 4 and 7 
ligands/nm , respectively. The reason that the PEG coverage was slightly larger than the 
expected number might be due to the free PEGs that noncovalently attached on the 
PEGylated BNPs.
2.3.3 The DA-OA-BNPs
The ligand exchange is a versatile method to convert the hydrophobicity of the 
ball-milled BNPs. Vitamin C with two hydroxyl groups that rigidly bonded on a 
heterocyclic ring was attached on the surface of the BNPs following the same procedure 
as DA coating (Figure 2.13). The resulting BNPs can disperse in aqueous solution after 
the ligand exchange, indicating the success of the vitamin C attachment. Moreover, the 
OA-BNPs produced by ball-milling with oleic acid as the boron stabilizer were produced 
and underwent the same ligand exchange procedure as UND-BNPs. The other 
experiments are based on the dopamine-coated BNPs produced by ligand exchange on 
the OA-BNPs.
The resulting DA-OA-BNPs showed better colloidal stability in water than the 
DA-UND-BNPs due to their larger surface charge. Table 2.1 shows the zeta potential 
discrepancy between the DA-UND-BNPs and DA-OA-B in aqueous solutions. The better 
dispersibility of DA-OA-BNPs was also demonstrated by TEM images. The particles are 
more separated from each other, and particle size and morphology were more uniform. 
The average diameter obtained from the TEM images is 18.2±3.1 nm (Figure 2.14).
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Figure 2.13. The molecular structure of vitamin C and oleic acid.
Table 2.1. Water suspension stability and zeta potential of DA-UND-B and DA-OA-B
Sample Stability in w ater Zeta Potential
DA-UND-BNPs 1 Day - 2.20 mV
DA-OA-BNPs months - 62.73 mV
Figure 2.14. The TEM images for DA-OA-BNPs.
The IR spectrum of DA-OA-BNPs shows that the dopamine was modified on the 
surface of the BNPs (Figure 2.15). The intensive peak at 1720 cm-1 is attributed to the 
C=O from the fatty acid residue on the BNPs. Not all of the fatty acids were replaced by 
dopamine, and the negative surface charge of DA-BNPs in aqueous solution contributed 
to the carboxyl groups left on the boron surface. The strong bands at 1210 cm-1 (C-N 
vibration) and 1550 cm-1 (NH2 scissoring) are characteristics of primary amine 
suggesting the presence of dopamine.
It is known that dansyl chloride reacts with primary amine and generates 
fluorescence emission under the UV irradiation. This approach is frequently used to 
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Figure 2.15. IR spectrum of DA-OA-BNPs.
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amount of DA-OA-BNPs and OA-BNPs were prepared by sonication. After the addition 
of the dansyl chloride solution, the DA-OA-BNPs suspension emitted the green 
fluorescence indicating the presence of primary amine on the DA-OA-BNPs particles. 
The OA-BNPs suspension was used as a comparison, which remained nonluminous 
under the UV light (Figure 2.16).
2.3.4 Prelim inary cell toxicity study of DA-BNPs^
Macrophages are immune system-related cells that are abundantly present at 
inflamed areas and many important organs such as the liver, lung, spleen, and bone
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Figure 2.16. The reaction of DA-OA-B with dansyl chloride generated fluorescence 
under the UV light (left); the OA-B ethanolic solution with the addition of dansyl 
chloride generated no fluorescence (right).
f performed with the help of Dr. Alexander Malugin, Department of Pharmaceutics and Pharmaceutical 
Chemistry, University of Utah.
marrow. Taking advantage of their ability to scavenge nanoparticles and their 
distribution, drug delivery researchers often study the interaction of the nano-carriers
38with macrophages. We performed preliminary biological evaluation of BNPs on a 
murine peritoneal macrophage cell line RAW264.7. This cell line possesses many 
essential characteristics of ‘professional’ phagocytes: it secretes lysozymes; expresses Fc 
receptors for immunoglobulins; and it is capable of antibody-dependent lysis of sheep
39erythrocytes and tumor cell targets, as well as pinocytosis and phagocytosis. RAW264.7 
cells are a widely used as a model cell line to study the interaction of nanomaterials with 
biological systems.
To avoid the potential interference from synthesis residues and solvents prior to 
incubation with the cells, DA-BNPs were purified by extensive dialysis against a large 
amount of millipore water. The resulting suspension was separated by ultracentrifugation; 
the supernatant collected and solid nanoparticles re-dispersed in water at 0.25 mg/mL 
concentration, which was determined gravimetrically. DA-BNPs were added to 
RAW264.7 cells at 10% (v/v) of the original concentration, and cells were incubated with 
DA-BNPs for 72 h. Cells treated with the same volume of millipore water containing no 
DA-BNPs were used as control. Since the particles and the supernatant were prepared at 
usual lab environment and were not sterile, bacterial contamination of cultured media 
was observed in 4-5 days. Incubation of RAW264.7 cells with DA-BNPs (or with their 
supernatant) resulted in no apparent changes of cell confluency or cell density, indicating 
that neither BNPs suspension nor the supernatant of freshly prepared plain BNPs 
appeared to be toxic toward RAW264.7 cells after 72 h of continuous incubation. The 
morphology of the RAW264.7 control cells and cells grown in the presence of DA-BNPs
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in the DMEM with 10% serum showed little difference (Figure 2.17). The majority of the 
cells in both cultures had a spherical morphology typical for RAW264.7 at high cell 
density. The only noticeable difference was a slightly higher proportion of spread, 
elongated cells with dendritic-like morphology in the culture treated with DA-BNPs. A 
similar phenomenon was observed with cells that incubated with the supernatant. These 
morphology changes due to the cytoplasmic spreading could be a result of macrophages 
activation, which was observed in the cells incubated with SiNPs.40
Rhodamine B isothiocyanate and FITC were attached to the DA-OA-BNPs in 
order to obtain fluorescently-labeled BNPs suitable for investigating the cellular uptake 
of DA-BNPs by macrophage cell lines, RAW 264.7. The rhodamine B and FITC labeled 
DA-BNPs incubated with RAW264.7 cells for 6  h, and the interaction of dye-labeled 
BNPs with RAW 264.7 cells was detected by confocal microscopy (Figure. 2.18). Black 
spots in Differential Interference Contrast Microscopy (DIC) images represented the 
aggregation of BNPs. The observable BNP aggregations were distributed on the cell 
membranes. The intensity of green color represented the rhodamine B-labeled BNPs, and 
purple color corresponded to the nucleus stained with DRAQ5 (magenta). Both diffused 
and spot-like fluorescence distributions were observed. Diffused fluorescence staining 
was found in the cytoplasm and nucleus of some cells indicating that dye-labeled BNPs 
enter RAW264.7 cells. Similar fluorescence staining was observed for FITC-labeled 
BNPs, but images were not taken due to bacterial contamination of the sample. It 
appeared that BNPs’ association with cells was uneven: there were cells completely 
without BNPs, and there were cells that accumulated a significant amount of BNPs.
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Figure 2.17. Phase-contrast images of RAW264.7 cells: (A) control; (B) incubated 
with DA-BNPs for 72 h; (C) incubated with DA-BNPs supernatant for 72 h Images 





Figure 2.18. Cellular internalization (association) of rhodamine-labeled BNPs (pseudo­
green) after 6  h incubation with RAW264.7 cells. Single plain scan was used for DIC 
and overlay images. Z-stack scans were used for fluorescence combined image. 
Representative images are shown. Scale bar is 20 pm.
2.4 Conclusion
We have developed a versatile method to attach dopamine to the surface of boron 
nanoparticles (BNPs) by replacing fatty acids on the surface. TGA and XPS 
measurements, as well as fluorescent-dye modification, confirmed that these 
nanoparticles carry dopamine ligands on their surfaces. DA-BNPs are water dispersible 
and DA-OA-B suspensions are colloidal stable in water for months. In the concentration 
studied, DA-BNPs did not show signs of toxicity toward murine macrophage cells and 
the DA-BNPs were able to enter the cells. These results suggest that DA-BNPs are 
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CHAPTER 3
TANNIC ACID-TEMPLATED LARGE-PORE MESOPOROUS SILICA
NANOPARTICLES
3.1 Introduction
Because of their unique features, such as mesoporous structures, high surface area
and easily functionalized surface, mesoporous silica nanoparticles (MSNs) have many
1 2 potential applications as delivery agents for drugs and biomolecules, and as host
materials for catalysis, imaging and sensing.3- 6 To fulfil this promise, MSNs should be 
created with a narrow size range in the nanoscale, preferably 50 to 200 nm, to facilitate 
entrance into the cell, and with large pores to encapsulate large pharmaceuticals and 
biomolecules such as proteins, enzymes and nucleotides. In the past decades, numerous 
strategies were developed to produce a variety of mesoporous silica materials with 
diverse morphologies, pore sizes and pore arrangements. 7 , 8 The particle size and 
morphology can be controlled by tailoring the molar ratio of silica precursor and 
surfactant; pH can be controlled by using base catalyst with the addition of co-solvents or 
organic swelling agents, and introduction of organoalkoxysilane precursors during the co­
condensation reaction.
Size of the particles is a crucial factor that affects their permeability into the tissue 
membranes in vitro and bio-distribution in vivo. A study comparing the cellular 
association of MSNs with different sizes by cancerous epithelial cells concluded that
cellular uptake of MSNs is size-dependent, and that cells uptake smaller particles better.9 
Therefore, the size control of the particles is crucial to design and synthesis materials for 
drug delivery systems. 10 Mou and coworkers have manipulated the diameter of the 
MCM-41 nanoparticles from 30 to 280 nm ; 11 however, the maximum pore size was 
limited to 6  nm, which limits their application as a carrier for adsorption and releasing
large molecules. SBA-15 is the most studied large-pore mesoporous material and was
12first reported by Stucky group. By varying the nonionic triblock-copolymer as the 
surfactant template, and the use of co-solvent and swelling agents, the pore size of SBA-
15 can be controlled from 6  to 50 nm. However, the size of the smallest SBA particles 
reported so far is around 500 nm, which is not suitable for intracellular applications. 13,14 
Ying et al. describe a method to produce polydispersed mesoporous SiNPs (50-300 nm) 
with tuneable pore sizes from 5 to 30 nm from a dual-surfactant system: a nonionic 
tricopolymer surfactant is used to template the porous structure (a swelling agent is used 
to increase the pore size) and a cationic fluorocarbon surfactant is used to manipulate the 
particle size. 15 However, the technique of controlling the uniformity of the dual­
surfactant templated MSNs is not fully developed. 16
Despite encouraging progress in controlling the morphology and pore size of the 
mesoporous materials, a simple route to synthesize monodispersed, relatively large-pore 
mesoporous silica nanospheres—whose sizes are smaller than 2 0 0  nm— still remains a 
challenge. Herein, we present a "one-pot" synthesis route of novel mesoporous silica 
nanoparticles with a tunable pore size from 5-13 nm by an ammonia catalyzed sol-gel 
reaction in the presence of an environmentally friendly nonsurfactant pore-forming agent, 
tannic acid (TA). The pore size of the tannic acid templated (TA-TEOS) silica
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nanoparticles (NPs) can be tuned from 4-13 nm. Additionally, the study of these new 
materials expands the field of mesoporous silica material chemistry and facilitates a 
better understanding of interactions between organic molecules and silanes.
Compared to the conventional MSNs, the TA-TEOS NPs have several advantages. 
First, TA is inexpensive, nontoxic and abundant in nature, whereas other surfactants are 
expensive, toxic and difficult to synthesize. In biomedical applications, traces of toxic 
surfactant left in the particles are unacceptable. Second, the simple "one-pot" synthesis 
route of TA-TEOS NPs is suitable for large scale industrial production. Third, TA-TEOS 
NPs are the first kind of MSN that achieves uniform size/shape, small dimension (200 
nm), and large pore size (13 nm)— at the same time making them excellent candidates for 
large molecule storage and drug delivery. Finally, the TA-TEOS NPs are capable of dual­
modification in the interior of the pores and on the external surface. With TA acting as a 
protecting agent for the interior of the pores, the external surface of the TA SiNPs can 
undergo conventional silica surface modification. Since the TA template is removed 
using water, there is no need to subject the particles to calcination or harsh acid 
conditions, which are necessary to remove traditional surfactants. Therefore, the surface 
ligands remain on the particles after the removal of the TA molecules from the pores. 
Once TA is removed, the interior of the pores can be further modified.
3.2 Experimental
3.2.1 Chemicals and instrum ents
Tannic acid (ACS-grade, Alfa Aesar), tetraethoxysilane (TEOS, 99.999+%, Alfa 
Aesar), ammonium hydroxide (28-30% as NH3, EMD Chemicals, Inc.), ethanol (200 
proof, ACS-grade, Pharmaco-Aaper), 3-aminopropyltriethoxysilane (APTES, 99%,
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Sigma-Aldrich), dansylchoride (Sigma-Aldrich), potassium phosphate monobasic 
(Sigma-Aldrich), potassium phosphate dibasic trihydrate (Mallinckrodt), sodium chloride 
(Mallinckrodt), sodium bicarbonate (Mallinckrodt), potassium chloride (Mallinckrodt), 
magnesium chloride (Aldrich), calcium chloride (Mallinckrodt), sodium sulphate 
(MACRON), sodium hydroxide (Mallinckrodt), Hydrogen Chloride 
(Sigma-Aldrich), tris(hydroxymethyl) aminomethane (Mallinckrodt), sodium silicate 
solution (Na2Si3O7, 20% SiO2, Mallinckrodt), ammonium molybdate tetrahydrate (Alfa 
Aesar), sulfuric acid (Fisher Scientific), oxalic acid dehydrates (Aldrich), L-ascorbic acid 
(Research Products International Corp.), lysozyme (from chicken egg white, Sigma- 
Aldrich), albumin (from bovine serum, lyophilized powder, Sigma-Aldrich), hemoglobin 
(from bovine blood, lyophilized powder, Sigma-Aldrich), P-Nicotinamide Adenine 
Dinucleotide Hydrate (P-NADH, Research Products International) and oxaloacetate acid 
(Sigma-Aldrich) were all used as received. Mitochondria Malic Dehydrogenase from 
porcine heart (ammonium sulfate suspension, Sigma-Aldrich) underwent dialysis in a 
0.5-3 ml 3500MWCO dialysis cassette against phosphate buffer for 18 h at 4°C. 
Acetonitrile (HPLC grade, VWR Scientific) was freshly distilled from calcium hydride. 
Millipore water (18 MQ • cm) used in all experiments was obtained from a Barnstead 
“E-pure” water purification system.
The visual characterization was carried out by scanning electron microscopy 
(SEM, FEI NanoNova instrument) and transmission electron microscopy (TEM, FEI 
Philips Tecnai T-12 instrument). The surface area and pore volume were measured by 
nitrogen sorption measurements, which were collected on a Micrometrics ASAP 2010 
(Norcross, GA) instrument at 77.3 K. All samples (~ 0.1 g) were degassed in the
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degassing port of the adsorption apparatus at 80 °C for approximately 6  h prior to the 
nitrogen sorption measurements. The surface-area measurement was based on the 
Brunauer-Emmett-Teller (BET) method by using adsorption data at relative pressure 
from 0.05-0.20. The pore-size distribution was based on the Barrett-Joyner-Halenda (BJH) 
method. Philips type PW3040/00 XPert Pro XRD (Spectris, England) using Cu K a  
radiation at 45 kV and 40 mA was used to analyse the X-ray Diffraction (XRD) patterns 
of TA SiNPs. The XRD spectrum was recorded in the 29 range of 1.8 -  10 with a step 
size of 0.02° in a 29 scattering angle and a scan speed of 0.01 degree/s. UV/Vis 
measurements were performed using an Ocean Optics USB4000 instrument or a Thermo 
Scientific Evolution 260 B10. The particle hydrodynamic size and zeta-potential 
measurements were conducted in water using a NICOMP 380 ZLS Zeta Potential/Particle 
Sizer (PSS • NICOMP Particle Sizing Systems). Thermogravimetric analyses were 
performed using a TA Instruments TGA 2950 Thermogravimetric Analyzer. A Vortex- 
Genie 2 laboratory mixer from Scientific Industries was used to re-disperse the protein- 
loaded SiNPs in the solutions.
3.2.2 P reparation of tannic acid-tem plated mesoporous silica nanoparticles
Tannic acid (TA) was thoroughly dissolved in 50 mL ethanol. Twenty-five mL of 
concentrated ammonium hydroxide were added to the ethanolic solution under vigorous 
stirring following the addition of TEOS. Water from the concentrated ammonium was the 
source of trace water for the sol-gel hydrolysis reaction to occurring. The onset of 
turbidity after the addition of TEOS indicated the start of silica sphere formation. After 2 
h of stirring, the particles were centrifuged out at 3400 rpm for 40 min and resuspended 
in water. The TA, and unreacted TEOS were removed by repeatedly washing with water
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and ethanol until the supernatants were colorless. After the final rinsing, the particles 
were air-dried overnight.
3.2.3 Preparation of 240 nm silica spheres
The nonporous SiNPs was prepared by hydrolysis and condensation of TEOS
17 18according to the Stober method, ’ which has been used as a model system to synthesize 
colloidal silica nanoparticles. 250.0 mL of an ethanolic solution containing TEOS (26.7 
mL, 0.10 mol) and an equal volume of an ethanolic solution containing NH4OH (13.4 
mL, 0.20 mol) and water (144 mL, 8.0 mol) were mixed together and vigorously stirred 
at room temperature. After 24 h, the mixture was then centrifuged and washed in a 
gradient series water/ethanol solution. After the final rinsing, the supernatant was 
decanted, and the silica spheres were dried under ambient conditions.
3.2.4 Degradation study of TA-TEOS
All the solutions were contained in polyethylene bottles. Simulated blood fluid 
(SBF) was made by mixing the following components: 7.996 g NaCl, 0.350 g NaHCO3, 
0.224 g KCl, 0.228 g K2HPO4 3 H2O, 0.305 g M gCh-6H2O, 0.278 g CaCh, 0.071 g 
Na2SO4, 40 ml of 1 M HCl and 6.075 g of tris(hydroxym ethyl) aminomethane with 
millipore water in a 1 L volumetric flask . 19
Standard silicic acid solution was made by diluting the sodium silicate solution 
(Na2Si3O7, 242.23 g/mol). Three stock solutions were prepared: 1) 3.1 g ammonium 
molybdate tetrahydrate dissolved in 50 mL 1M sulfuric acid. 2) 6.3 g oxalic acid 
dehydrates dissolved in 50 mL milipore water. 3) 1.76 g ascorbic acid dissolved in 50 mL 
millipore water. Sonication was used to help dissolve the salts. A calibration curve was 
made using the standard silicic solutions with concentrations of 1.72 x 10-5M, 8.56 x 10-
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5M, 1.703 x 10-4M, 2.54 x 10-4M, 3.37 x 10-4M, and 4.195 x 10-4M . 100 pL of solution 1 
was added to 2 mL of the sample. After 10 min, the solution became yellow due to the 
formation of thephosphate molybdenum complex. A hundred pL of solution 2, which 
removes the interfering phosphate molybdenum complex, were then added and the 
yellow color faded in 1 min. The addition of 100 pL of solution 3 resulted in the blue 
color of the solution. The mixture sat for another 10 min to allow the completion of the 
blue complex formation. The wavelength of the blue molybdenum-complex peak is at 
810 nm in UV-vis adsorption. By the UV-vis absorbance measurements, the 
concentration of silicic acid was obtained.
Ten mg of 240 nm Stober SiNPs and TA-TEOS NPs were separately dispersed in
20 ml of millipore water or SBF. An aliquot of each solution was taken out and 
centrifuged hourly. A hundred pL of each supernatant were diluted by 2 ml of water or 
SBF, and the resulting solutions were tested by the aforementioned procedure.
3.2.5 Surface modification of tannic acid-tem plated 
mesoporous silica nanoparticles
To modify the surface of TA-TEOS with primary amine functionalities, 15 mg 
TA-TEOS NPs were redispersed in 10 ml freshly distilled acetonitrile by soni cation. 
After the addition of 0.2 ml APTES, the solution was stirred under nitrogen flow 
overnight. The aminated particles were collected by centrifugation and washed 
extensively with distilled acetonitrile five times to remove the excess APTES. The amine 
modified TA-TEOS was dried in the air and stored in powder form.
67
3.2.6 Prelim inary study of protein adsorption
Ten mM pH 6  phosphate buffer was prepared by mixing 0.136 g K2HPO4 3H2O 
and 1.280 g KH2PO4 in 1 L milipore water.
Thirty mg of both Stober SiNPs and TA-TEOS NPs were separately dispersed 
into 6.0 mL pH 6 , 10 mM phosphate buffer (pH 6 , 10 mM) and each colloidal solution 
was then divided into three 2 mL aliquots. Individual stock solutions (0.1 mM) of Lz, 
BSA and BHb were prepared in the same buffer and 2.0 mL of each were added 
separately to an aliquot of nonporous SiNPs and TA-TEOS NPs followed by incubation 
for 24 h at ambient conditions. The mixtures were centrifuged (40 min, 3200 rpm), and 
the UV/Vis absorbance was recorded for each of the supernatants.
The protein adsorption rate studies monitored the amount of protein adsorbed by 
TA-TEOS for 24 h in the phosphate buffer. 40 mg of TA-TEOS NPs were suspended in 8 
mL phosphate buffer, then mixed with an additional 8 mL of 0.1 mM protein phosphate 
buffer solution. One and a half mL aliquots were periodically removed and centrifuged, 
and the supernatant was analyzed by UV spectroscopy.
The protein release from the loaded TA-TEOS was studied in phosphate buffer 
with 0.1 M of potassium chloride by redispersing 10 mg of protein-loaded TA-TEOS in 8 
mL of phosphate buffer at room temperature by a vortex mixer. At each time interval, 1.5 
mL of the solution were withdrawn, and the particles were isolated by centrifugation. The 
protein concentration in the supernatant was analyzed by UV-vis spectrophotometer.
3.2.7 Enzyme immobilization by TA-TEOS
The m-MDH was stored as an ammonium sulfate suspension at 4°C. Before all 
the experiments, the enzyme was transferred to phosphate buffer by dialysis (Slide-A-
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Lyzer Dialysis Cassettes with 3.5K MWCO cutoff, Thermal Scientific) for 18 h at 4 °C. 
The resulting enzyme solution was concentrated in a centrifuge filter by centrifugation, 
and the concentration was calculated using the calibration curve attained from the 
standard BSA assay.
A hundred mM phosphate buffer was prepared by mixing 15.223 g 
K2HPO4 3H2O and 4.536 g KH2PO4 in 1 L millipore water and was adjusted to pH 7.5 
with 12 M KOH solution.
Identical concentrations of particles (2.5 mg/mL) and enzymes (0.05 mM) as the 
previous protein immobilization experiment were used. Two hundred and forty nm 
Stober method SiNPs were used as a nonporous reference. The particle suspensions and 
the m-MDH phosphate buffers were mixed together and followed by incubation for 24 h 
at ambient conditions. The mixtures were centrifuged (10 min, 12000 rpm), and the 
UV/Vis absorbance was recorded for each of the supernatants.
3.2.8 Enzyme activity test
A lower concentration of m-MDH phosphate buffer (100 mM, PH 7.5) was 
prepared. 5 mg/mL TA-TEOS and nonporous 240 nm SiNPs incubated in the m-MDH 
solution for 2 days at 4°C to allow the complete adsorption of m-MDH at low 
temperature. The m-MDH-loaded particles were separated from the enzyme stock 
solution via centrifugation for 40 min at 6000 rpm and 4 °C. The particles were 
redipersed in phosphate buffer by the vortex mixer for 10 min. The solution was then 
tested for its catalysis activity via a standard method described below. Two fresh stock 
solutions were prepared before each experiment: 1) 0.14 mM P-NADH phosphate buffer 
solution, 2) 7.6 mM oxaloacetate phosphate buffer solution. 1.4 mL of 1) was added to
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the cuvette followed by the addition of 50 pL 2) and 50 pL sample solution. The mixture 
was shaken by hand and quickly put into the spectrometer. The reading of absorbance at 
340 nm was recorded at 15 or 30 s intervals for 5 min. A free m-MDH solution with the 
same concentration of the enzyme as the ones loaded in the TA-TEOS was prepared. The 
catalysis activity was measured following the procedure previously described. Blank 
samples with phosphate buffer instead of the sample solution were also prepared and 
tested as references.
3.3 Results and discussion
3.3.1 Synthesis and characterization of TA-TEOS NPs
Surfactants such as CTAB, triblock copolymers and others are the usual pore- 
forming agents that self-assemble into micelles, creating the voids in the silica matrix 
during the preparation of mesoporous silica materials. The electrostatic interactions 
between the ionic surfactant and silicate species direct the formation of the mesoporous 
structure. For the non-ionic surfactants, the hydrogen bonding between the surfactants 
and the silicate is suggested to be the main driving force. There are a number of groups 
who produced mesoporous silica materials utilizing nonsurfactant templates. Wei et al. 
reported the synthesis of mesoporous silica materials achieved by NaOH and HCl
catalyzed sol-gel methods through incorporation of dibenzoyl-L-tartaric acid, D-glucose
20 21and D-maltose into the silica frameworks. ’ The resulting materials have large surface 
areas, narrow pore size distribution (smaller than 4 nm), and disordered pore assembly 
upon the removal of the organic compounds.
In our study, TA is used as the pore-forming agent for the first time in the 
preparation of mesoporous silica nanoparticles by base-catalized hydrolysis of TEOS
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(Sukhishvili et al. and Tsukruk et al. employed TA as a component in the hydrogen-
22, 23bonded layer-by-layer films. ’ ). TA is a polymer of gallic acid and glucose molecules 
with multiple hydroxyl groups which partially deprotonate in the basic condition (Figure 
3.1). There are no reports about the self-assembly of TA. However, we assume that 
similar to the anionic surfactants, the negatively charged TA could have electrostatic 
interactions with ionic ammonium and silicic acid. In addition, although the sol-gel 
reaction took place under the basic conditions with a low acidity (pKa~10), not all the 
hydroxyl groups are deprotonated; as a result, they form H bonds between the TA and the 
soluble silicic acid species. We believe that the electrostatic and H-bonding interactions 
are the main driving force for the TA to form some supramolecular structure that imparts 
the formation of large voids in the silica framework.
One advantage of using TA is that it is a cheap and environmentally friendly pore- 
directing agent compared to the expensive and toxic surfactants used in other synthesis 
methods of mesoporous materials. As a natural molecule found in many plants, tannic
24acid is generally recognized as safe by the FDA to be used as a food additive. It is also
25- 27an effective antioxidant that is proven to be anti-mutagenic and anti-carcinogenic. 
With its unique structure and properties, tannic acid also displays great potential in
28 29materials synthesis. Phillip et al. and Zhang et al. reported the synthesis of Au 
nanoplates and nanoparticles using tannic acid as both a reducing and a stabilizing agent. 
Xu et al. prepared a cross-linked chitosan/attapulgite composite resin by an emulsion
30method using TA as an imprinting template to enhance the adsorption of TA.
Several batches of the TA-TEOS were prepared to optimize the synthesis 




Figure 3.1. a) Tannic acid molecular structure. b) TA 3D structure in different 
directions.
31because it affects the reaction rate and the morphology of the product. Hydrolysis and 
polycondensation reaction rates accelerated with the increasing concentration of the 
catalyst. The higher concentration of ammonium hydroxide led to the formation of SiNPs 
with larger size. The ammonium hydroxide concentration was fixed at 1/3 of the total 
reaction solution volume in the synthesis of TA-TEOS for two reasons. The relatively 
high concentration of ammonium hydroxide quickly produced TA-TEOS. Moreover,
when the volume ratio of ammonium hydroxide added was less than 30%, turbidity 
appears. With further addition of ammonium hydroxide, the TA ethanolic solution 
became clear again with a red color (Figure 3.2).
The pore size of TA-TEOS was tuned from 5-13 nm by varying the TA 
concentration. TA4-TEOS, TA8 -TEOS, TA16-TEOS and TA32-TEOS were prepared by 
adding 5.3 x 10-4 M, 10.6 x 10-4 M, 2.13 x 10-3 M, 4.26 x 10-3 M TA separately into each 
reaction solutions. The samples prepared from diverse TA concentrations were analyzed 
via TEM, SEM, and nitrogen adsorption-desorption measurements.
The size distribution and surface morphology were characterized by SEM. The 
SEM images demonstrate that the TA8 -TEOS and TA16-TEOS particles were mostly 
spherical and monodisperse with negligible aggregation, and TA concentration had little 
influence of the sizes of the silica nanospheres. TA4-TEOS particles were less uniform, 
but presented a comparable average size with TA8 -TEOS and TA16-TEOS. Due to their 
irregular shapes, TA32-TEOS exhibited agglomeration, and the average size of the 
TA32-TEOS particles was larger than the other samples.
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Figure 3.2. The picture of TA-EtOH-NH4OH mixtures. The sample on the right is TA- 
EtOH without addition of NH4OH. With increasing amount of NH4OH added to the 
solution the mixture became milky than clear red.
As shown by TEM (Figure 3.4), TA4-TEOS, TA8 -TEOS, TA16-TEOS possess 
increasing porosity, similar to what was observed for most of the templated materials 
where the increase in the templating molecule concentration leads to a more porous 
structure. However, too much TA present in the reaction disturbs the formation of the 
spherical particles, and irregularly shaped, rough-surface solid agglomerates were
obtained in the sample TA32-TEOS (Figure 3.3). High concentrations of template
12molecules preventing the pore formation were reported by other groups.
The accurate measurement of TA-TEOS surface area and pore morphology is 
necessary to develop the applications of the particles in adsorption and separations. For 
the ordered mesoporous particles, which have cylindrical, close-packed pores, the
32porosity description is relatively straightforward and well-defined; while in the case of 
the non-surfactant molecule templated particles, exploring the amorphous structure 
remains a challenge. Nitrogen sorption analysis can be used to characterize the surface 
area, pore size distribution, and other porosity related profiles. The sample is degased 
first to expel the adsorbed gases; it is placed in a vacuumed sample tube where the 
temperature is maintained at the cryogenic temperature, and exposed to nitrogen. With 
the increase of pressure, the nitrogen molecules are adsorbed on the surface of the 
particles and the pressure at each adsorption equilibrium state and the amount of nitrogen 
adsorbed is recorded. In the process of desorption, while the pressure is systematically 
reduced, pressure and the amount of nitrogen adsorbed are also recorded.
The Brunauer-Emmett-Teller (BET) surface area, pore volume and pore 
parameters listed in Table 3.1, confirm the presence of uniform pores, large surface area 
and pore volume for the particles prepared with relatively small amounts of TA. In
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Figure 3.3. SEM images of tannic acid template silica nanoparticles produce with 
different amount of tannic acid: a) TA4-TEOS; b) TA8 -TEOS; c) TA16-TEOS; d) 
TA32-TEOS.
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Figure 3.4. TEM images of tannic acid template silica nanoparticles produce with 
different amount of tannic acid: a) TA4-TEOS; b) TA8 -TEOS; c) TA16-TEOS; d) 
TA32-TEOS.
general, an increase in the TA concentration in the template-containing solutions results 
in a larger surface area and pore volume. The nitrogen sorption measurements show type
IV isotherms for the TA4-TEOS, TA8 -TEOS and TA16-TEOS with two distinct
33adsorption steps, which are characteristic of a mesoporous structure (Figure 3.5). The 
small hysteresis loops around 0.3 p/p0, 0.5 p/p0, and 0.7 p/p0 correspond to the pore size 
distribution centered at 6 , 10 and 13 nm, respectively (Figure 3.5). The hysteresis loop at
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Table 3.1. The textural parameters of TA-TEOS from the N2 sorption measurements





TA4-TEOS 419.9 0.46 5.9
TA8 -TEOS 445.4 0.82 9.7
TA16-TEOS 560.6 1.53 12.9
TA32-TEOS 9.4 0 .1 2 ---
a) BJH Adsorption average pore width
higher relative pressure (about 0.9) can be attributed to inter-particle porosity. In the case 
of TA32-TEOS, the N2 sorption isotherm shows a type II isotherm characteristic of 
macroporous material (>50 nm) with only one hysteresis loop at higher pressure due to 
the agglomeration of the particles. The BET surface area of TA32-TEOS is 9.4 m2/g, 
which is comparable to nonporous silica nanoparticles.
We also studied the influence of the reaction time on the nanoparticle morphology. 
The SEM and TEM images of the products of the 2, 6 , and 24 h reactions (TA-TEOS-2h, 
TA-TEOS-6 h, TA-TEOS-24h) are shown in Figure 3.6. All of the reactions produced 
monodisperse nanoparticles with rough surfaces. However, only TA-TEOS-2h and TA- 
TEOS-6 h displayed a porous structure, while nonporous structure was observed for TA- 
TEOS-24h particles. The core of TA-TEOS-24h had high density so that the TEM could 
not confirm the inner structure of these samples. In order to better understand the 
formation of the TA-TEOS at different reaction times, TGA was conducted to analyse 



















































Figure. 3.6. TEM images of tannic acid template silica nanoparticles produced in 
different reaction times: a) 2 h; b) 6  h; c) 24 h.
ranging from 35 to 200 °C was mostly attributed to the degradation of silanol groups, and 
the weight loss above 200 °C was due to the calcination of TA (Figure 3.7). According to 
the TGA analysis, TA-TEOS-24h had a larger weight loss in the higher temperature 
range compared to the other two samples. The difference of weight loss suggests that TA- 
TEOS-24h contains more TA. A possible explanation for this is that TA formed a 
supramolecular structure with TEOS by the hydrogen bonding at the beginning of the 
reaction; after 2 h, the excess TEOS molecules entered the interior of the particles and 
continued to condense in the pores and on the external surface of the particles to form a 
silica shell, which eventually blocked the pores completely. Because of the blocking of 
the pores, TA could not be removed by water extraction; it remained inside the particles, 
which was detected by TGA analysis. Moreover, the ashes of TA-TEOS-2h and TA- 
TEOS 6 h displayed a blue color after the calcination due to the carbonization of the TA 
residues. At the same time, because the TA was trapped inside the TA-TEOS-24h 
particles, the color of the ash of TA-TEOS-24h remained white.
The ashes obtained after the TGA measurements were analysed by SEM. 
According to the SEM images, calcination at 800 °C did not induce the collapse of the 
TA16-TEOS, indicating these TA16-TEOS SiNPs have thick silica walls and high 
thermal stability. However, in the case of the TA32-TEOS SiNPs, the irregularly shaped 
particles fused together after the calcination.
As seen in the TEM images, the contrast of the TA-TEOS SiNPs at the center is 
low due to the disordered pore arrangement. The XRD spectra of TA-TEOS SiNPs did 











Figure 3.7. TGA data of tannic acid template silica nanoparticles: a) produce by 
different reaction times; b) modified with amine groups.
a
b
TA-TEOS particles. In contrast, the well-ordered hexagonal or cubic arrangements of the 
pores in periodic mesoporous silica materials give diffraction patterns in powder X- 
raydiffraction experiments. The disordered arrangement in our particles likely resulted 
from the inability of TA to form regular micelles with well-defined geometries. In 
addition, the fast condensation generally leads to a less condensed and less ordered silica 
framework.17
All our later experiments used the TA16-TEOS-2h particles which had large pore 
sizes. In addition to electron microscopy, the hydrodynamic size and water dispersibility 
of TA-TEOS were measured by DLS. According to DLS, the TA16-TEOS particles have 
an average hydrodynamic diameter of 249.2 ±60.5  nm. Due to the shrinkage during the 
electron microscopy experiments, the sizes of the TA16-TEOS particles obtained by 
SEM were smaller than those measured by DLS (193.6 ±  14.2 nm). Zeta potential 
measurements showed that TA-TEOS nanoparticles were highly negatively charged (­
37.8±3.5 mV), indicating a fairly stable suspension in aqueous medium, and resistance 
to aggregation due to the electrostatic repulsions.
3.3.2 D egradability of TA-TEOS NPs
Although the degradation of silica is fairly slow, mesoporous SiNPs with higher 
surface area have more interaction with water which increases the degradation rate of the 
material. 34 Moreover, disordered structures are more vulnerable to dissolution.35 Herein, 
we describe our preliminarily studies of the degradation behavior of TA-TEOS NPs in 
water and in simulated blood fluid (SBF).
The degradation rate of TA-TEOS NPs was monitored through the well- 
established molybdenum blue colorimetric method, which has been used to detect the
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trace concentrations of monosilicic acids. The molybdenum ions react with monosilicic 
acid and reveal a blue color due to the formation of siliconmolydbate complex. 36,37 TA- 
TEOS SiNPs and 240 nm SiNPs synthesized by the Stober method were dispersed in 
millipore water and SBF. An aliquot of each suspension was taken out and centrifuged 
hourly in the first 5 h, and then every 24 h. The supernatants were measured by the 
molybdenum blue method. The molybdenum blue test detected the releasing of silicic 
acid in 3 days, which showed the degradation behaviors of different SiNPs (Figure 3.8). 
When immersed in water, the TA-TEOS NPs showed a constant degradation rate. The 
Stober particles were barely degradable in water. They exhibited a faster degradation rate 
in SBF; but after 48 h, the degradation rate slowed down and the silicic acid 
concentration eventually remained constant. The degradation rates in water were slower 
than in SBF because calcium and magnesium ions in SBF affect the degradation behavior
38 39of silica. ’ TA-TEOS NPs showed a faster degradation rate compared to the Stober 
particles in both solvents. TA-TEOS NPs degraded quickly during the first 8 hours in 
SBF, then the degradation slowed down; this is similar to the degradation behavior of 
MCM-41 nanoparticles reported by the Chen group, 40 who reported that the degradation 
of MSNs proceeds in different stages: fast bulk degradation in the first several hours, and 
a decelerated degradation blocked by the formation of calcium and magnesium silicate 
layer on a day-scale.
The morphology changes of TA-TEOS NPs induced by degradation were 
observed by SEM and TEM as shown in Figure 3.9. The pore openings became larger 
and detectable by SEM after the TA-TEOS NPs were immersed in water for a month. 







Figure 3.8. Silicic acid released by TA-TEOS and Stober SiNPs in water and SBF.
SBF for one day. Moreover, the particles that were immersed in SBF for a month became 
flower-like in shape. The slow degradation of TA-TEOS with larger diameter of pore 
openings suggests future application of the particles as drug delivery agents, which could 
slowly release the guest molecules.
3.3.3 Surface modification of TA-TEOS
Removal of the template by solvent extraction from TA-TEOS nanoparticles 
exposes silanols on the external surface and inside the pores, which can be silylated.41 A 
variety of functional groups such as amine, thiol and carboxyl groups can be attached to 
the silica nanoparticles, facilitating further conjugation with various guest species such as 
imaging dyes or targeting ligands.
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Figure 3.9. SEM images of TA-TEOS a) as made; b) in water (pH7) for a month; c) in 
SBF for a day; d) in SBF for a month. TEM images of TA-TEOS e) in milipore water 
for a month f) in SBF for a day.
The amination procedure of Stober SiNPs was also applicable to the TA-TEOS 
particles. Herein, we used one of the most commonly used silane-coupling agents, 3- 
aminopropyltriethoxysilane (APTES) to attach primary amine groups onto the outer- and 
inner-surfaces of the porous silica particles. The characterization of amine modified TA- 
TEOS particles (NH2-TA-TEOS) was done by using colorimetric method, TGA and zeta 
potential measurements. The fluorescence generated by the reaction between dansyl 
chloride and primary amines is a simple qualitative method to test the presence of 
primary amines. After the addition of two drops of dansyl chloride, ethanolic solutions of 
NH2-TA-TEOS glowed under UV irradiation; the unmodified TA-TEOS solutions did 
not fluoresce at all (Figure 3.10). The quantitative measurement of amine coverage on the 
TA-TEOS particles was achieved through TGA, where a significantly larger weight loss 
of the NH2-TA-TEOS compared to TA-TEOS was measured. As shown in Figure 3.6, 
the TGA of NH2-TA-TEOS under N2 displayed 1.7% weight loss from 35 to 200 °C for 
dehydration of silanols in the silica structures, and 9.5% weight loss from 200 to 800 °C 
for the decomposition of the amines. Using the TA-TEOS surface area of 560 m /g, and 
assuming that the amine groups were evenly distributed both onto the external and 
internal surfaces, the surface coverage is estimated to be about 1 amine per nm . This 
reasonable coverage density suggests successful attachment of the amine groups both 
onto the external surface and into the pores. This should allow functional moieties to be 
attached inside the pores of TA-TEOS particles, which would efficiently protect them 
from the outside environment. In addition to the TGA results, the zeta potential of the 
NH2-TA-TEOS, which was 18.2 ±  0.6 mV, demonstrated the presence of positively 
charged amine groups on the particles.
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Figure 3.10. Left vial contained TA-TEOS and right vial contained NH2-TA-TEOS, 
both in the presence of dansyl chloride under UV light.
3.3.4 Prelim inary study of physical adsorption of proteins
In the past decade, mesoporous silica materials with large pore diameter attracted 
attention to be used as adsorbents for various biomolecules.42-44 Immobilizing proteins 
inside the nanopores not only protects them from the environment and increases the 
stability of proteins to heat, pH and chemicals, but also has the possibility of enhancing 
the bioactivity of the proteins whose structure would be confined in the restricted pore 
space.45,46 However, the one-dimensional channel system of periodic mesoporous silica 
particles do not have interconnecting pores with each other, rendering them ineffective as
47carriers for biomolecule loading. One objective of this work was to investigate the 
possible application of TA-TEOS particles as protein carriers. Since the pore morphology 
of nanopaticles is considered to be one of the key conditions causing different
efficiencies of biomolecule uptake, the study of protein adsorption by the TA-TEOS 
nanoparticles, which have unique pore structures, would broaden our knowledge with 
respect to biomolecule adsorption by porous materials.
It is known that protein adsorption is strongly influenced by the relative sizes of 
the proteins and nanopores, 48 the pH of the solution, 49 and the surface characteristics of 
the porous materials and the proteins. Since TA-TEOS particles were purified by solvent 
extraction, there are abundant silanol (Si-OH) groups on the surface of the particles. The 
TA-TEOS surfaces possess a negative charge of -37.8±3.5 mV in water, and a slightly 
less negative charge of -25.5 ± 3 .6  mV in 10 mM PBS (pH 6 ) (Table 3.2), because of the 
salt effect. The major driving forces of protein adsorption by silica materials are 
electrostatic interactions50 and hydrogen bonding51 between the silanol groups and the
52 52, 53carboxylic or amino groups in the protein molecules. Lysozyme (Lz), ’ bovine 
hemoglobin (BHb) 54 and bovine serum albumin (BSA) 52,55 were chosen as model 
proteins in this work for their relatively smaller dimensions compared to the size of the 
mesopores of TA-TEOS particles, varied isoelectric points as listed in Table 3.3, and the 
large amount of information available in literature. The concentration of the proteins was 
measure using UV/Vis analysis (Figure 3.11). The equilibrium adsorption capacities and 
kinetic characteristics of the three probe proteins on the TA-TEOS were studied.
Nonporous silica nanoparticles with an average diameter of 244.8 ±  13.8 nm were 
synthesized by the Stober method and served as a reference. The three proteins were 
adsorbed more significantly by the porous TA-TEOS NPs compared to the Stober 
particles due to the greater surface area, as well as larger amounts of silanol groups of 
TA-TEOS (Table 3.4). In addition, the significant increase in the protein adsorption by
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(10mMPBS + 0.1M KCl, 
mV)
TA-TEOS 37.8±3.5 -25.5±3.6 -1.4±0.3
Stober SiNPs 49.9±0.0 -49.2±0.2 -4.0±0.3
Lz - 10.0±0.3 1.5±1.2
BHb - 12.7±0.3 -0.7±0.3
BSA - -13.6±0.1 -2 .0 ±0 .2
Table 3.3. Properties of the proteins selected in this study 52-55
lysozyme bovine hemoglobin bovine serum
albumin
Dimensions (nm) 3.2 6.4 x 5.5 x5 4 x 4 x 14
pI 11.4 7.4 4.8
Mass (KDa) 14 64 67
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Figure 3.11. Calibration curves of lysozyme, bovine hemoglobin, bovine serum 
albumin.
Table 3.4. The summary of protein adsorption by TA-TEOS and nonporous SiNPs
Initial Cone. TA-TEOS

















2 7 .5 ± 4 4  
3 1 .0= 2.8 
9 .7= 3 .1 
11 .2= 1.4 
2 3 .8= 2.6
77 . 1 = 1 2 4
3 9 6 .5= 35.8
130 .0 ± 4 1 4
3 1 .3= 3.9
3 0 4 .5= 33.7
1 .2 = 1 4
2 1 .3= 2.4
0
0
8 .5= 1 .7
3 .3= 3 .9 
2 7 2 .7= 30.9 
0 .5± 0.9 
0
1 0 9 .2= 22.3
BSA KC1 0.05 2 4 = 3.1 3 2 .2= 40.9 0 .6± 0.6 8 .2 = 7 4
the TA-TEOS illustrated that the proteins were not only adsorbed on the external surface 
of the particles, but also immobilized inside the mesopores. The positively charged 
lysozyme and hemoglobin possessed a greater affinity to the TA-TEOS NPs compared to 
the negatively charged BSA. Although the nonporous silica NPs absorbed a negligible 
amount of BSA, TA-TEOS trapped a noticeable amount of this negatively charged 
protein via hydrogen bonding (Table 3.4). Here the pore size was a key factor that 
strongly influenced protein capacity and uptake rate because the diffusion rate is 
geometry-dependent, 56 and a relatively wide pore opening allows protein molecules to
57enter the pores of the particles with less resistance. In addition, the large volume of the 
mesopores ensured the abundant adsorption capacity of proteins. The different adsorption 
of proteins by TA-TEOS NPs created potential application of TA-TEOS NPs in protein 
separation.
The kinetic plots of the proteins adsorbed by the TA-TEOS are shown in Figure 
3.12. Because of the large pore openings, the protein adsorption rate of TA-TEOS 
particles is faster than the MCM-41 and SBA particles,52,58 which make TA-TEOS 
particles more efficient protein adsorbents. The smallest protein, lysozyme, reached its 
saturation in 3 h, while the larger proteins, BHb and BSA, reached their saturation points 
in 6 and 8 h. The different adsorption rates could also make the TA-TEOS a potential 
material for protein separation.
To confirm that the hydrogen bonding played a crucial role in the adsorption of 
proteins, salts were added to the protein solution to screen electrostatic interactions. In 
0.1 M KCl solution, zeta-potentials of silica particles and of the proteins were close to 











Figure 3.12. Adsorption kinetics of TA-TEOS particles.
conditions. However, the fact that a significant amount of proteins, in particular BHb, 
was still uptaken by the TA-TEOS in the presence of KCl illustrated that hydrogen 
bonding played a central role in the protein adsorption by TA-TEOS NPs (Table 3.4). 
Since the adsorption capacities of the particles were affected by the ionic strength of the 
solution, we hypothesized that proteins initially loaded under lower ionic strength 
condition could be released under higher ionic strength conditions. The particles loaded 
with proteins in 10 mM phosphate buffer were redispersed in 8 mL 10 mM phosphate 
buffer in the presence of 0.1 M KCl by votex. One and a half mL of each sample was 
taken out in the time intervals of 1, 3, 5, 7 and 24 h, and the supernatants were obtained 
by centrifuging the particles. The UV absorbance of the supernatants allowed measuring 
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Figure 3.13. Protein-releasing kinetics of TA-TEOS and nonporous SiNPs.
adsorption of larger proteins on TA-TEOS appeared to be irreversible; meanwhile the 
small globular protein, lysozyme, with its low molecular weight, was slightly released by 
the TA-TEOS particles. None of the other proteins desorbed from the solid silica 
particles. The intensities below 0.15 were induced by the light scattering from the SiNP 
residues that were not completely removed by the centrifugation.
3.3.5 Immobilization of mitochondrial malic dehydrogenase
Immobilized proteins, such as enzymes and antibodies, are useful in catalysis, 
sensors, and separation applications due to their potential to improve the stability and 
activity under extreme conditions59 Malic Dehydrogenase (dimentions = 6.4 x 6.4 x4.5 
nm, isoelectric point = 8.0-8.560) is an enzyme found in animals. This protein contains 
two identical subunits with a combined molecular weight of 70K Da. Eukaryotic cells 
contain two different types of malate dehydrogenase: mitochondrial (m-MDH) and 
soluble or cytoplasmic (s-MDH). In our work, we used mitochondrial Malic
Dehydrogenase from porcine heart (m-MDH) to study the catalytic activity of 
immobilized enzymes. The reason for choosing this enzyme is that it is relatively cheap; 
it participates in many biological cycles; the detection of its catalytic behaviour is simple 
and straightforward; and abundant knowledge is available in literature. Furthermore, m- 
MDH has similar molecule weight, dimensions and isoelectric point to BHb, which we 
successfully immobilized in TA-TEOS NPs, as discussed in the previous section. Thus, 
we expected that m-MDH would be adsorbed into the pores of the TA-TEOS.
We studied the adsorption of m-MDH by TA-TEOS SiNPs using the same 
conditions as in the protein adsorption experiments above. The nonporous Stober 
particles with the diameter of 240 nm were used as a reference. The adsorption data is 
shown in Table 3.5. The adsorbed amount of m-MDH by TA-TEOS NPs was double the 
amount of enzyme that was adsorbed by nonporous SiNPs, indicating that the enzymes 
were immobilized not only on the external surface of the TA-TEOS NPs, but also inside 
the pores (Table 3.5). Moreover, the fact that adsorption behavior of m-MDH was
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Table 3.5 The m-MDH adsorption by TA-TEOS and nonporous SiNPs
TA-TEOS Stober SiNPs
Initial Conc. (mM) 0.05 0.05
m-MDH Adsorption % 31.4±1.0 15.9±1.4
m-MDH Adsorption (mg/g) 420.7±12.9 213.6±18.8
comparable with BHb (Table 3.2) indicates that proteins possessing comparable size, 
weight and surface charge show similar adsorption capacity on the SiNPs, which is not 
significantly affected by the primary and secondary structures of the biomolecules (eg. 
the amino acid sequence).
Our earlier adsorption experiments were conducted at room temperature, which 
may cause the denaturation of the enzymes. To test the m-MDH catalytic activity, the 
adsorption took place in the refrigerator, where the temperature was maintained at 4 °C. 
Since it is known that the diffusion rate depends on temperature, we incubated the 
particles with the enzyme at 4 °C for a longer time period, 2 days, to ensure the 
completion of the maximum adsorption of m-MDH. The concentration of the enzyme 
solution was lower than in the protein adsorption capacity experiments because high 
enzyme concentrations led to faster catalysis, which could not be recorded by the UV-vis 
spectroscopy. The resulting solutions were centrifuged at 4 °C and the particles loaded 
with m-MDH were redispersed in phosphate buffer. The catalytic reaction of m-MDH 
(Figure 3.14) took place at pH 7.5 and at room temperature to maximize the activity of 
m-MDH. By measuring the UV-Vis absorbance of P-NADH at the wavelength of 340 nm, 
which indicated the converting amount of oxaloacetic acid into maleic acid, we obtained 
the activity of the enzymes immobilized on the TA-TEOS and on nonporous SiNPs. A 
solution of free enzymes with the same concentration as the enzymes that were adsorbed 
by the TA-TEOS particles was prepared as a reference. Both of the immobilized m-MDH 
and free m-MDH solution were diluted a 100 fold due to the fast reaction rate.
Figure 3.15 shows the change of P-NADH concentration as a function of time. 








































Figure 3.15. Catalysis activities of m-MDH immobilized in TA-TEOS and nonporous 
SiNPs and free m-MDH with the same concentration as the immobilized ones.
activities. The activity of m-MDH immobilized on the TA-TEOS was calculated using 
the equation below:
Units (AAtest(min) — AAblank(min)) x  Vf(mL ) x  d f  
mL 6.22 x  Ve(mL)
where Vf is the total volume of the assay, df is the dilution factor, 6.22 is the millimolar 
extinction coefficient of P-NADH at 340 nm, and Ve is the volume of enzyme used. 
According to the calculations, the average activity of m-MDH immobilized in TA-TEOS 
at room temperature was 56.8±2.9, while it was 11.6±0.4 for the m-MDH immobilized in 
nonporous SiNPs. The difference in activity is due to the different immobilization 
locations of the enzymes and the amount of the enzymes. In nonporous SiNP the m-MDH 
was adsorbed only on the surface while in the case of TA-TEOS, the enzymes were 
immobilized both on the external surface and inside the pores of the particles. The 
amount of the enzyme that was adsorbed by TA-TEOS was double the amount adsorbed 
by nonporous SiNPs, while the activity of m-MDH on TA-TEOS exceeded those on the 
nonporous SiNPs by five times. We conclude that the m-MDH that were adsorbed inside 
the pores have higher activity than the ones that were immobilized on the surface. The 
free enzymes have a four-fold higher catalytic activity (202.4) compared to the enzymes 
trapped inside the pores because the free enzymes are more accessible to the oxaloacetate 
molecules.
The denaturation of the enzymes at room temperature was evident by the reduced 
catalytic activity as shown in Figure 3.16. The activity of free m-MDH decreased 40-fold, 









Figure 3.16. Catalysis activity of free m-MDH and m-MDH immobilized in TA-TEOS 
at room temperature.
temperature. At the same time, the enzymes loaded in the TA-TEOS did not show any 
reduction of reaction rate, and the conversion percentage of P-NDAH remained at 76%, 
which means the enzymes were protected by the silica matrix. The denaturation of m- 
MDH was due to the unfolding of the 3D structure of the enzyme in room temperature. 
The enhanced thermal stability of the m-MDH immobilized in TA contributed to the 
confinement of the 3D structure of the enzyme in the mesopores. This discovery is 
consistent with the report of Orita et al. 61 who immobilized antibodies into the MSNs 
with various pore sizes. Although the antibodies that were immobilized deeper in the 
large-pore MSNs showed lower activity, they possessed better stability in organic 
solvents and under thermal treatment.
3.4 Conclusion
We developed the use of tannic acid (TA) as a template to form a new type of 
relatively monodisperse mesoporous silica nanoparticles with a large pore volume and 
narrow pore size distribution. The particles were synthesised in the mixture of ethanol 
and ammonia giving them uniform, nearly spherical shapes with diameters smaller than 
200 nm. The pore size could be tuned from 5 to 13 nm by varying the concentration of 
TA. Fluorescent tags were attached onto the surfaces and into the interior of the particles 
after the amination of the particles with APTES. We have explored the potential 
applications of the new materials in protein immobilization. The mesoporous TA-TEOS 
nanoparticles showed a high protein adsorption capacity of 77.1 mg/g for Lz, 396.5 mg/g 
for BHb and 130.0 mg/g for BSA in PBS buffer. The effects of electrostatic interactions 
and hydrogen bonding were illustrated by increasing the ionic strength of the media. We 
also demonstrated that TA-TEOS nanoparticles can encapsulate an enzyme, m-MDH, 
which showed enhanced stability at room temperature compared to the enzyme in free 
solution; and higher catalytic activity compared to the enzyme adsorbed on the surface of 
nonporous SiNPs. The TA SiNPs can be considered a prototype mesoporous SiNP that 
inspires the discovery of new mesoporous SiNPs prepared using other nonsurfactant 
molecules with rigid structure and abundant sites that are able to associate with silica 
precursors as a pore-generating template.
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CHAPTER 4
DEGRADABLE BRIDGED SILSESQUIOXANE 
SILICA NANOPARTICLES
4.1 Introduction
Silica nanoparticles (SiNPs) offer an attractive platform for biomedical
1 2applications such as drug delivery and bioimaging, biocatalysis and bio-sensing. 
Silica consists of silicon and oxygen atoms connected by very strong covalent bonds 
making SiNPs not particularly biodegradable and not vulnerable to microbial attacks. In 
this respect, their application in vivo is problematic due to the accumulation of SiNPs in 
the liver, kidneys, bladder, spleen and lungs.4 To obviate this problem, degradable silica- 
based materials have been proposed and synthesized.5,6 Several recent reports describe
7 10some destabilization of silica by preparation conditions and inclusion of
biodegradable polymers, such as poly(L-lactic acid) .11,12 Doping metal cations into the 
silica matrix alters the composition of the SiNPs13, 14 and consequent removal of the 
cations by diffusion and chelation results in the destabilization of the silica structure.
SiNPs with controllable sizes from 20 to 1000 nm can be produced according to 
the well-established Stober method. 15 Traditionally, the silica precursor used is 
tetraethoxysilane or tetramethoxysilane. We hypothesized that the incorporation of 
organic groups into SiNPs will result in tunable destabilization and porosity of silica. 
Although a number of SiNPs have already been produced from individual
organosilanes, 16 the organically modified silica nanoparticle technology is not fully 
developed.
Our hypothesis was that the silica lattice could be effectively destabilized by 
introducing degradable organic groups into its structure, leading to the formation of more 
hydrolysable SiNPs. Our goal was to achieve silica biodegradability via an entirely new 
approach— by using bridged silsesquioxane precursors. Recently, bridged silsesquioxane 
was used as a silica precursor to produce functional silica nanomaterials. 17- 19 However,
there are only a few publications about the synthesis of spherical bridged silsesquioxane
20SiNPs. This chapter will describe the preparation of new hybrid SiNPs, including the 
design and synthesis of bridged silsesquioxanes with a cleavable ester as the linker; 
preparation of hybrid SiNPs; and investigation of the degradability of the novel particles. 
We expected that when the particles are placed in an aqueous environment, the ester 
would hydrolyze and this would weaken the structure, making degradable particles.
4.2 Experimental
4.2.1 Chemicals and instruments
All reagent-grade chemicals were used as received. Chloromethyl ester (CME, 
Alfa Aesar), 3-aminopropyltriethoxysilane (APTES, 99%, Sigma-Aldrich), ethylene 
glycol (EG, Mallinkrodt), tetraethoxysilane (TEOS, 99.999+%, Alfa Aesar), ammonium 
hydroxide (NH4OH, 28-30% as NH3, EMD Chemicals, Inc.), anhydrous potassium 
carbonate (K2CO3, EMD Chemicals, Inc.), 3-isocyanatopropyltriethoxysilane (ICPTES, 
Gelest), D-sorbitol (Sigma-Aldrich), sodium silicate solution (27% SiO2, Riedel-de Haen), 
ammonium molybdate tetrahydrate (Alfa Aesar), sulfuric acid (Fisher Scientific), oxalic 
acid dehydrates (Aldrich), L- ascorbic acid (Research Products International Corp.) were
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all used as received. Dichloromethane (CH2Cl2, reagent grade, Fisher Scientific) and 
triethylamine (Sigma-Aldrich) were freshly distilled. N,N-dimethylformamide (DMF, 
Mallinckrodt) was dried by anhydrous magnesium sulphate (Mallinckrodt). Methanol 
(ACS Reagent, Sigma-Aldrich), ethanol (200 proof, ACS-grade, Pharmaco-Aaper) and 
isopropyl alcohol (MACRON) were used as solvents without further purification. 
Millipore water (18 MQ • cm) used in all experiments was obtained from a Barnstead 
“E-pure” water purification system.
The visual characterization was carried out by scanning electron microscopy 
(SEM, FEI NanoNova instrument) and transmission electron microscopy (TEM, FEI 
Philips Tecnai T-12 instrument). All the electronic spectrometry samples were prepared 
by drying particle from aqueous or ethanolic suspensions on silica nitride wafers for SEM 
or on holey carbon-coated Cu grids for TEM. The surface area and pore volume were 
measured by nitrogen sorption measurements, which were collected on a Micrometrics 
ASAP 2010 instrument at 77.3 K. All samples (~ 0.1 g) were degassed in the degassing 
port of the adsorption apparatus at 80 °C for approximately 6 h prior to the nitrogen 
sorption measurements. The surface-area measurement was based on the Brunauer- 
Emmett-Teller (BET) calculation method in a linear, relative pressure range between 0.05 
and 0.25, and the pore-size distribution was based on the Barrett-Joyner-Halenda (BJH) 
method. UV-Vis measurements were performed using an Ocean Optics USB4000 
instrument using a quartz cuvette. The particle hydrodynamic size and zeta-potential 
measurements were conducted in water using a NICOMP 380 ZLS ZetaPotential/Particle 
Sizer (PSS • NICOMP Particle Sizing Systems) at room temperature. Thermogravimetric 
analyses were performed by using a TA Instruments TGA 2950 Thermogravimetric
107
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Analyzer under an N2 atmosphere from 35 to 800 °C at a heating rate of 20 °C/min. FT- 
IR spectrometer (Thermo Scientific Nicolet 8700 model) was used for surface functional 
group detection. A Clay Adams Compact II Centrifuge (3200 rpm, Becton Dickinson) 
and ultracentrifuge Sorvall RC5B Plus (15000 rpm on a SA-600 rotor) were used for all 
centrifugations.
4.2.2 Synthesis of chloromethyl ester bridged 
(3-aminopropyl) triethoxysilane
All glassware was cleaned with millipore water and dried in the oven prior to use. 
Ten point two six mL (0.044 mol) of APTES and four g of anhydrous K2CO3 were added 
into a 250 mL round-bottomed flask with 100 mL of dichloride methane. One point seven 
six mL (0.02 mol) of CME were added to the flask, drop wise. The mixture was stirred 
and refluxed for 36 h under nitrogen atmosphere in an oil bath. After cooling down to 
room temperature, the K2CO3 was removed by filtration. The chloromethyl ester bridged 
(3-aminopropyl) triethoxysilane (CME-APTES) was obtained by rotary evaporation.
Figure 4.1 shows the reaction. 1H NMR (300 MHz, CDCl3, 5): 8.28 (s, 1H), 5.73 (s, 2H), 
3.86 -  3.75 (m, 12H), 3.22 (dd, J = 12.9, 6.8 Hz, 2H), 3.04 -  2.94 (m, 2H), 1.87 (dt, J = 
15.3, 7.8 Hz, 2H), 1.74 -  1.54 (m, 2H), 1.28 -  1.14 (m, 18H), 0.77 -  0.56 (m, 4H).
O r a g ,  K2C O 3
N2; Reflux 36h
O
Figure 4.1. The synthesis o f CME-APTES silsesquioxane.
4.2.3 Preparation of CME-APTES silica spheres
Both hydrochloride and ammonium hydroxide were employed as acid and base 
catalysts, respectively, for the sol-gel reaction. Water from the concentrated ammonium 
hydrochloride was the source of water for the sol-gel hydrolysis reaction to occur. Varied 
amounts of 2 M HCl and concentrated NH4OH were added to ethanol solutions of CME- 
APTES. After stirring for 2 h under N2, the materials were separated by centrifugation 
and purified with multiple washes with ethanol and water.
4.2.4 Preliminary study of degradation behavior 
of CME-APTES silica spheres
Ten mg of CME-APTES particles were suspended in 3 mL of either basic or 
acidic solution for different time spans. The resulting particles were centrifuged and 
washed with water. DLS, SEM and TEM were employed to visualize the changes in 
morphology of the particles.
4.2.5 Synthesis of ethylene glycol bridged isocyanatopropyltriethoxysilane
Fifteen mL of anhydrous MgSO4-dried DMF were flushed repeatedly with 
nitrogen in the 50ml round bottom flask in an oil bath. After the addition of 27.9 pL (0.5 
mmol) of ethylene glycol and 264.4 pL (1.05 mL) of 3-isocyanatopropyltriethoxysilane 
(ICPTES), the flask was heated to 80 °C. The reaction continued under nitrogen for 12 h 
and cooled to room temperature. The product was rotary-evaporated and characterized by 
NMR. Figure 4.2 shows the reaction of ethylene glycol bridged 
isocyanatopropyltriethoxysilane synthesis. 1H NMR (300 MHz, CDCl3) 5 8.21 (s, 2H), 
4.62 (s, 4H), 3.94 -  3.66 (m, 12H), 3.30 -  3.05 (m, 4H), 1.68 -  1.51 (m, 4H), 1.31 -  1.13 

















Figure 4.2. The synthesis of ICPTES-EG silsesquioxane.
4.2.6 Synthesis of ethylene glycol bridged isocyanatopropyltriethoxysilane
particles
The ICPTES-EG SiNPs were produced by co-condensation. Point four g of 
ICPTES-EG were dissolved in 9 mL of ethanol by sonication, followed by the addition of
3 mL of NH4OH and 0.304 mL of TEOS. The mixture was stirred at room temperature 
for 2 h. The resulting particles were collected by centrifugation, and washed with ethanol 
and water to remove ammonium hydroxide and the excess of silica precursors. The 
resulting particles were air-dried and stored in powder form.
4.2.7 Synthesis of sorbitol-bridged isocyanatopropyltriethoxysilane
Sorbitol-bridged isocyanatopropyltriethoxysilane (ICPTES-sorbitol) was prepared
21following a published approach. Point two g of sorbitol were added to 3 mL dry DMF 
in a round bottom flask, soaked in an oil bath under continuous flow of nitrogen. The 
temperature was elevated to 40 °C to accelerate the dissolving rate of sorbitol. When the 
sorbitol fully dissolved in DMF, 306 [xL of freshly distilled triethylamine and 542 ^L of
ICPTES were added to the mixture. The temperature of the solution was maintained at 90 
°C for the next 3 days. The product consisting of pale yellow solids was collected by 
rotary evaporator. The reaction is shown in Figure 4.3. 1H NMR (300 MHz, CDCl3, 5):
8.01 (s, 2H), 4.36 -  4.00 (m, 4H), 3.90 -  3.72 (m, 12H), 3.70 (s, 2H), 3.14 (d, J = 22.3 Hz, 
4H), 1.87 (s, 6H), 1.62 (s, 6H), 1.32 -  1.12 (m, 18H), 0.62 (s, 4H).
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4.2.8 Synthesis of sorbitol bridged isocyanatopropyltriethoxysilane SiNPs
The ICPTES-sorbitol SiNPs were synthesized by co-condensation of TEOS with 
ICPTES-sorbitol under the basic condition. The reaction conditions were manipulated to 
achieve the optimum production of monodisperse silica spheres. A typical ICPTES- 
sorbitol SiNPs synthesis method is described as follows: point zero four g of ICPTES- 
sorbitol were dissolved in 10 mL of ethanol by 1 h sonication. Any remaining 
undissolved solids were excluded from the reaction by using the clear supernatant. Five 
mL of NH4OH were added to this supernatant followed by the addition of 0.06 mL of 
TEOS with vigorous stirring. The onset of turbidity after a short while indicated the start 
of silica sphere formation. The reaction was conducted at room temperature for 2 h. The 






Figure 4.3. The synthesis o f ICPTES-sorbitol silsesquioxane
SiNPs synthesized under the same condition without the addition of ICPTES-sorbitol 
were also prepared as a reference. All the resulting particles were air-dried and stored in 
powder form.
4.2.9 Synthesis of 340 nm SiNPs
The 340 nm silica spheres were prepared according to modifications of previously
22reported procedures. Five hundred mL of an ethanolic solution containing TEOS (51.4 
mL, 0.20 mol) was mixed with 500.0 mL of an ethanolic solution containing NH4OH 
(70.0 mL, 1.1 mol) and water (257 g, 14.3 mol). These two solutions were poured 
simultaneously in a 2 L Erlenmeyer flask and vigorously stirred. The resulting mixture 
has final concentrations of 0.2 M TEOS, 1.1 M NH3 and 17.0 M H2O. After 24 h, the 
mixture was then poured into 15 mL centrifuge tubes and centrifuged for 10 min. The 
supernatant was discarded, leaving the spheres as pellets at the bottom of the centrifuge 
tubes. Purification of the spheres was achieved by a repetitive cycle of suspending the 
spheres via sonication for 10 min followed by centrifugation for 10 min in a gradient 
series of 10 mL supernatant: 100% water, then 25% ethanol, then 50% ethanol, then 
twice in 75% ethanol, and finally in 100% ethanol. After the final rinsing, the supernatant 
was decanted and the silica spheres were air-dried overnight.
4.2.10 Molybdenum blue colorimetric experiment
All the solutions were contained in polyethylene bottles. Standard silicic acid 
solution was made by diluting sodium silicate solution (Na2Si3O7, 242.23 g/mol). Three
23solution stocks were prepared: (1) 3.1 g of ammonium molybdate tetrahydrate dissolved 
in 50 mL of 1 M sulfuric acid, (2) 6.3 g of oxalic acid dihydrate dissolved in 50 mL of 
millipore water and (3) 1.76 g of ascorbic acid dissolved in 50 mL of millipore water.
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Sonication was used to help dissolve the salts. In order to make a calibration curve, the 
standard silicic solutions with concentrations of 1.72 x 10-5 M, 8.56 x 10-5 M, 1.703 x 10­
4 M, 2.54 x 10-4 M, 3.37 x 10-4 M, and 4.195 x 10-4 M respectively were prepared. 100 
p,L of Solution 1 was added to 2 mL of the sample. After 10 min, the solution became 
yellow due to the formation of yellow phosphate molybdenum complex. 100 ^L of 
Solution 2 was then added and the yellow color faded in 1 min. The addition of 100 ^L of 
Solution 3 resulted in a color change to blue. The mixture was allowed to sit for an 
additional 10 min until the completion of the blue complex formation. The UV-vis 
spectrum featured a molybdenum blue peak at 810 nm. The concentration of silicic acid 
was calculated from the calibration curve.
10 mg of 340 nm Stober SiNPs and ICPTES-sorbitol SiNPS were each separately 
dispersed in 20 mL of millipore water. An aliquot of each solution was centrifuged every 
hour. 100 ^L of each supernatant was diluted by 2 mL of water, and the resulting 
solutions were tested by the procedure aforementioned.
4.3 Results and discussion
4.3.1 Synthesis of bridged silsesquioxanes
The aim of this project was to produce novel degradable SiNPs by using 
alkoxysilane precursors carrying organic groups to destabilize the silica network. 
Aryltrialkoxy- and diaryldialkoxysilanes were tried first due to the assumption that their 
electron-withdrawing aromatic structure might weaken the Si-O bonds. However, 
because of the steric repulsion, the aryltrialkoxy- and diaryldialkoxysilanes did not form 
monodisperse SiNPs. Thus, an alternative strategy of introducing bridged silsesquioxane
113
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with cleavable linkers into the silica network was performed (Figure 4.4). We synthesised 
a series of ester-bridged silanes as silica precursors, including the chloromethyl ester 
(CME)-bridged silane, ethylene glycol (EG)-bridged silane, and sorbitol-bridged silane. 
While the preparation of the sorbitol-bridged silane was accomplished according to the
bridged silanes.
4.3.2 Synthesis and characterization of CME-APTES SiNPs
There are currently no reports on the synthesis of CME-APTES in the literature, 
thus the reaction conditions were adapted from other reactions involving the APTES and
The column silica gel, which contains moisture, accelerates the degradation of the silane 
since the carbamate linkers of CME-APTES are highly hydrolysable. Moreover, the high 
affinity between the silica gel and product silane prolonged the retention time in the 
column during purification, which further enhanced the hydrolysis of the product. As 
verified by its NMR spectrum, the column-purified sample degraded into some other 
products, while the unpurified product revealed expected NMR peaks. The product was 
stored in a dessicator to prevent the degradation caused by the moisture in the air. The 
NMR spectrum of CME-APTES stored in the dessicator for a week displayed some noise
21approach published by the Corriu group, we also developed the synthesis of two new





Figure 4.4. Schematic illustration o f bridged silsesquioxane with cleavable linker.
peaks indicating degradation of the silane. Therefore, to produce the hybrid SiNPs, 
freshly produced bridged silsesquioxane products were used.
The goal of this project was to produce spherical and monodispersed degradable 
SiNPs for bio-applications. Various reaction conditions that were used to optimize the 
preparation conditions of CME-APTES SiNPs are listed in Table 4.1. Both HCl and 
ammonium hydroxide were used to catalyse the hydrolysis and condensation of bridged 
silsesquioxanes. It is known that acidic conditions are more likely to yield silica gels or
25other soft networks of silica rather than uniform particles. In our case, the acid- 
catalysed products were irregularly shaped aggregates. In the base-catalysed reactions, 
the ratio between ammonium hydroxide and ethanol, the amount of the silica precursor, 
as well as the reaction time were manipulated to obtain spherical nanoparticles. With a 
low ratio (< 1:3) between the ammonium hydroxide and ethanol, the reaction solution 
remained clear after 2 h and no particles were obtained after the centrifugation. Therefore, 
we increased the concentration of the catalyst in order to accelerate the reaction. With 
extremely high concentration of ammonium hydroxide (1:2 v/v), we obtained silica gel 
after 2 h with and without stirring. Based on the SEM images of products prepared by 
various reaction conditions, we focused on CME-APTES-B-3-02, which corresponds to 
SiNPs synthesised under the condition of 1:3 ratio of ammonium hydroxide and ethanol 
with 0.2 g of CME-APTES (Figure 4.5). The hydrodynamic diameter of CME-APTES is 
shown in table 4.2. After the CME addition, the mixture became opalescent in several 
minutes and became increasingly opaque in the following hours, indicating the growth of 
the particles. The resulting particles were spherical with an average diameter of 2.3±0.2 
p,m. Reaction time was varied from 2 h to 18 h. The resulting particles showed increasing
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Table 4.1. Production conditions for CME-APTES SiNPs




CME-APTES-HCl-10-01-2h 1 ml HCl 2M 10 mL 0.1 g 2 hours
CME-APTES-HCl-3-01-2h 3 ml HCl 2M 9 mL 0.1 g 2 hours
CME-APTES-HCl-10-02- 18h 1 ml HCl 2M 10 mL 0.2  g 18 hours
CME-APTES-B-10-01-2h 1 ml NH4OH 10 mL 0.1 g 2 hours
CME-APTES-B-3-02-2h 3 ml NH4OH 9 mL 0.2  g 2 hours
CME-APTES-B-2-02-2h 4 ml NH4OH 8 mL 0.2  g 2 hours
CME-APTES-B-1-02-2h 5 ml NH4OH 5 mL 0.2  g 2 hours
CME-APTES-B-3-04-2h 3 ml NH4OH 9 mL 0.4 g 2 hours
CME-APTES-B-3-02-4h 3 ml NH4OH 9 mL 0.2  g 4 hours
CME-APTES-B-3-02-6h 3 ml NH4OH 9 mL 0.2  g 6 hours
CME-APTES-N-3-02-18h 3 ml NH4OH 9 mL 0.2  g 18 hours
Figure 4.5. SEM images of CME-APTES-B-3-04-2h (CME-APTES SiNPs).
size polydispersity with longer reaction time. Below, CME-APTES-B-3-02-2h is referred 
to as CME-APTES SiNPs.
Because of the low yield of CME SiNPs, another kind of SiNPs involving the use 
size polydispersity with longer reaction time. Below, CME-APTES-B-3-02-2h is referred 
to as CME-APTES SiNPs. of CME-APTES silane was produced. TEOS is commonly 
used as a silica precursor.16 CME-APTES co-condensed with TEOS led to the formation 
of nanoparticles wherein the TEOS reinforced the spherical skeleton; while the 
organosilane CME-APTES, which is assumed to be uniformly present throughout the 
particle body, destabilized the particles. Different reaction times, namely 2 h and 18 h, 
were employed with a high concentration of NH4OH (1:3 v/v). The resulting particles had 
no significant differences in size and morphology according to the SEM images. Similar 
to CME-APTES SiNPs, the synthesis conditions were optimized. The resulting CME- 
APTES-TEOS SiNPs were polydisperse according to the DLS data. This was due to the 
aggregation of the particles as shown in the SEM and TEM images (Figure 4.6).
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4.3.3 Degradation of CME-APTES SiNPs
The CME-APTES particles were difficult to disperse in aqueous solutions. The 
DLS data showed aggregation of the particles in water even after hours of sonication 
(Table 4.2). The CME-APTES SiNPs dissolved in 1 M NaOH solution in 30 min, while 
the reference 340 nm SiNPs produced via Stober method fully dissolved in the same 
solution after 45 min. The dissolution of the particles was monitored by DLS. DLS data 
of CME-APTES SiNPs in water and under acidic condition (HCl pH=2) are summarized 
in Table 4.2. The SEM images showed that after 3 days under the acidic condition, the 
diameter of the particles decreased, and the residue of the dissolved material was 
observed around the particles (Figure 4.7). The particles shrank continuously and started 
to aggregate after 10 days. With a longer immersion time, the particles formed irregularly 
shaped aggregates.
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Table 4.2. DLS data of CME-APTES SiNPs
Average Diameter Distribution
CME SiNPs 1580.9 ± 274.7 nm 100%
CME SiNPs in acid 3 days 341.1 ±76.3 nm 87.6%
1800.1 ± 320.9 nm 12.4%
CME SiNPs in acid 10 days 215.1 ±51.3 nm 85.8%
1800.1 ± 172.3 nm 14.2%
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Figure 4.7. SEM images of CME-APTES SiNPs in a) ethanol b) HCl solution for 3 
days and c) HCl solution for 10 days
All stability tests for CME-APTES-TEOS SiNPs were based on the particles that 
were synthesised under the conditions of 0.4 g CME-APTES silane, 0.38 mL of TEOS,
3.8 mL of NH4OH and 11.4 mL of ethanol. The degradability of the CME-APTES- 
TEOS SiNPs was tested under the acidic conditions. The agglomeration of the particles 
dispersed after 6 days in acidic solution is shown in SEM images, and was also 
corroborated by DLS data (Table 4.3). The high-resolution TEM images showed that the 
edge of the particles degraded and became smoother after the immersion in acidic 
solution (Figure 4.8). After 2.5 months, the particles dissolved into flakes and no 
aggregation or spherical particles were observed. In contrast, the SiNPs synthesised 
without CME-APTES remained spherical with no obvious shape change in the acidic 
solution. The preliminary results from the degradability tests verified that by using the 
cleavable bridges silsesquioxane as the silica precursor, degradable silica nanoparticles 
can be created. However, both of the CME-APTES and CME-APTES-TEOS NPs 
suffered from aggregation, which might cause adverse effects in biomedical applications. 
Thus, we prepared other ester-bridged silsesquioxanes and explored their ability to 
produce degradable SiNPs.
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Table 4.3. DLS data of CME -TEOS SiNPs
Average Diameter Distribution
CME-APTES-TEOS SiNPs 626.6 ± 103.6 nm 62.3%
2428.3 ± 302.5 nm 37.7%
CME-APTES-TEOS SiNPs in acid 6 days 240.5 ± 45.7 nm 91.9%
1132.6 ± 186.0 nm 8.9%
CME-APTES-TEOS SiNPs in acid 2.5 months 19.7 ± 1.1 nm 100%
121
Figure 4.8. TEM images of CME-APTES-TEOS SiNPs (a,b) in ethanol, (c,d) in acidic 
solution for 10 days. SEM images of e) CME-SiNPs in HCl solution for 1.5 months 
and f) CME-SiNPs in HCl solution for 2.5 months.
4.3.4 ICPTES-EG SiNPs
ICPTES-EG does not form nanoparticles by itself under the basic catalysis. With 
the use of TEOS as a co-condensation agent, we were able to obtain small particle 
clusters, which were observed using SEM and TEM (Figure 4.9). After 1 week in HCl 
solution, significant coalescence took place to form larger clusters. This appreciable 
interparticle conglutination is likely due to the continuous hydrolysis and condensation of 
the silica particles.
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Figure 4.9. SEM images of a,b) ICPTES-EG-TEOS SiNPs c) ICPTES-EG-TEOS 
SiNPs in HCl solution for 1 week d) TEM image of ICPTES-EG-TEOS SiNPs.
4.3.5 Synthesis and characterization of ICPTES-Sorbitol SiNPs
The ICPTES-sobitol was synthesized according to a published method. The 
ICPTES-sorbitol has two carbamate functionalities as cleavable sites. Sorbitol is used as 
a sweetener in the food industry. It is nontoxic and can be absorbed and recycled by the 
human body;26 hence the degradation of the ICPTES-sorbitol should not induce adverse 
biological reactions.
Similar to ICPTES-EG, the use of pure ICPTES-sorbitol did not produce SiNPs. 
Thus, we first intended to coat 50 nm Stober SiNPs27 with ICPTES-sorbitol shell under 
the basic catalysis conditions. Preshrunk SiNPs (subjected to a thermal treatment up to 
600 °C for 4 h) were used first. After the overnight reaction, the particles could be 
separated from the solution by 3400-rpm centrifugation, while the Stober 50 nm 
nanoparticle required 15000-rpm centrifugation to collect. However, the shorter 
centrifugation time was not due to the increase of the particle size, but due to the 
aggregation caused by the addition of ICPTES-sorbitol, which interconnected the 
particles. 50 nm SiNPs and the SiNPs with the addition of ICPTES-sorbitol showed 
similar average size: 80.2 ± 9.3 nm and 76.0 ± 5.6 nm. We had hoped that by doubling 
the amount of the bridged silsesquioxane we would be able to grow a shell around the 
original SiNPs. However, no increase in the particle size was observed. Fresh 50 nm 
SiNPs were prepared because they possess higher density of the silanol groups on the 
surface, which offer more condensation sites for ICPTES-sorbitol. The zeta potential of 
preshrunk SiNP (-34.6 ± 0.2 mV) vs. fresh SiNPs (-47.0 ± 0.5 mV) illustrated that the 
fresh SiNPs had higher silanol coverage because the negative surface charge was mainly 
due to the negatively charged silanol groups. We tried two different concentrations of
123
21
ICPTES-sorbitol to produce the shell, but according to SEM, no silica shell was formed 
onto the particles.
Spherical SiNPs were only produced when the ICPTES-sorbitol functioned as a 
co-silica precursor and co-condensed with TEOS under the basic condition. We 
optimized the concentration ratios of precursors, solvent and catalyst as listed in Table 
4.4. We confirmed particle formation under different reaction conditions by SEM. Longer 
reaction time led to the aggregation of the particles, assuming that the particles were 
formed in the first 2 h due to the fast hydrolysis and condensation rate. Then the excess 
silica precursors condense loosely on the surface of the particles forming 
interconnections between the particles. The ratio between the TEOS and ICPTES-sorbitol 
also played a critical role, where the spherical shape mainly depends on TEOS 
concentration (Figure 4.10). Too much ICPTES-sorbitol prevented the formation of the 
uniform spherical structure of the particles; on the other hand, too much TEOS led to the 
formation of particles with limited degradability. Therefore, after several trials, we found 
that the best ratio between the ICPTES-sorbitol and TEOS was approximately 1:5, which 
led to the formation of uniform nanospheres with the largest proportion of the 
organosilane as the degradable component and average diameter of 122.2±12.3 nm. The 
typical spherical ICPTES-sorbitol SiNPs are shown in Figure 4.11.
As a control, TEOS SiNPs nanoparticles were synthesized under the same 
condition as ICPTES-sorbitol-7 (referred to as ICPTES-sorbitol) (Table 4.4) without 
adding ICPTES-sorbitol and utilizing TEOS as the only silica source. The reference 
SiNPs synthesized from TEOS condensation had the average diameter of 426.9±28.8 nm 
(Figure 4.11), which was significantly larger than the hybrid ICPTES-sorbitol SiNPs.
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Table 4.4. The reaction conditions of ICPTES-sorbitol SiNPs.
ICPTES-sorbitol TEOS EtOH NH4OH Time
1 0.2 g (3.0x10-4 mol) 0.15 ml (6.8x10-4 mol) 10 mL 5 mL 18 hours
2 0.2 g (3.0x10-4 mol) 0.3 ml (1.4x10-3 mol) 10 mL 5 mL 18 hours
3 0.2 g (3.0 x10-4 mol) 1 ml (4.5x10-3 mol) 10 mL 5 mL 18 hours
4 0.2 g (3.0 x10-4 mol) 1 ml (4.5x10-3 mol) 11.25 mL 3.75 mL 18 hours
5 0.2 g (3.0 x10-4 mol) 2 ml (9.0x10-3 mol) 12 mL 4 mL 18 hours
6 0.02 g (3.0x10-5 mol) 0.03 ml (1.4x10-4 mol) 10 mL 5 mL 2 hour
7 0.04 g (6.0x10-5 mol) 0.06 ml (2 .8 x10-4 mol) 10 mL 5 mL 2 hours
Figure 4.10. SEM images of ICPTES-TEOS SiNPs synthesized with increasing (a < b 
< c) concentration of TEOS.
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Figure 4.11. SEM images of a) ICPTES-sorbitol NPs and b)SiNPs produced in the 
same condition using TEOS as the only silica precursor.
The TGA measurements also demonstrated the incorporation of organic groups in the 
ICPTES-sorbitol NPs. 10 mg of ICPTES-sorbitol NPs and reference SiNPs were 
analyzed by TGA, and the weight loss from 35-800 °C was recorded. The weight loss 
under the temperature of 150 °C resulted from the loss of moisture while the weight 
losses at higher temperature were attributed to the calcination of the organic groups 
(Figure 4.12). A weight loss difference of 6.2% between the ICPTES-sorbitol SiNPs and 
TEOS SiNPs suggested that the ICPTES-sorbitol was incorporated into the silica network 
of the ICPTES-sorbitol SiNPs. Assuming the 6% weight loss all comes from the organo 
substituents, 1.5% molar of ICPETS-sorbitol was incorporated into the hybrid SiNPs by 
calculation. The incorporation percentage of ICPTE-sorbitol was much lower than the 
initial molar ratio of ICPTES-sorbitol that added to the reaction solution. The excess of 
ICPTES-sorbitol was removed by centrifugation.
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Figure 4.12. TGA data of ICPTES-sorbitol SiNPs and TEOS SiNPs
4.3.6 Degradability of ICPTES-Sorbitol SiNPs
The ICPTES-sorbitol has carbamate groups that are easily hydrolyzed in acidic
28 5solutions (Figure 4.13). Carbamate hydrolysis half-lives range from seconds to 10 
years depending on the substituent groups. In our case, the ICPTES-sorbitol is a primary 
carbamate which hydrolyzes much faster than the secondary carbamates.
To study the hydrolysis of ICPTES-sorbitol SiNPs, zeta potential measurememts, 
IR, and colorimetric spectroscopic methods were employed. The ICPTES-sorbitol SiNPs 
were suspended in HCl aqueous solution (pH=4) and, after 12 days, the particles were 
collected from the solution and washed with water to remove the HCl. The particles were 
redispersed in water. The zeta potential measurements of fresh ICPTES-sorbitol SiNPs 
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Figure 4.13. Hydrolysis of ICPTES-sorbitol.
Table 4.5. Zeta potential of ICPTES-sorbitol NPs
Sample Zeta-Potential 
ICPTES-Sorbitol-TEOS -44.3±0.5 mV 
ICPTES-Sorbitol-TEOS-HCl 12d 42.0±0.8 mV
fresh ICPTES-sorbitol SiNPs was similar to the Stober particles where the large negative 
charge results from the surface silanol groups. For ICPTES-sorbitol SiNPs treated with 
acid for 12 days, the positive zeta potential demonstrated that the dominant groups on the 
SiNPs had changed from silanols to positively charged groups.
There are several possible hydrolysis products: carboxylic acids or primary 
amines according to the mechanism of carbamate hydrolysis. Since the zeta potential of
the hydrolyzed particles was positive, we believe that the ICPTES-sorbitol hydrolyzed 
into primary amines in the silica network. In order to verify our assumption, a 
colorimetric experiment was designed. Dansyl chloride is a fluorescent dye that emits 
green fluorescence after adduct formation with primary amines. Several ICPTES-sorbitol 
suspensions at different pH were prepared along with suspensions of Stober particles for 
reference. After the addition of 3 drops of dansyl chloride solution, the ICPTES-sorbitol 
suspension treated at pH 4-8 exhibited green fluorescence under the UV light indicating 
the presence of primary amines on the particles. On the other hand, the ICPTES-sorbitol 
SiNPs treated at pH 2 solution and the Stober particles showed no obvious fluorescent 
emission (Figure 4.14). This is in agreement with the report from the Yeh group that
29silica nanotubes were resistant to degradation at very acidic conditions. One can take
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Figure 4.14. Dansyl chloride reacted with primary amines from the hydrolysis of the 
particles: (left to right) ICPTES-sorbitiol SiNPS in pH 2, pH 4, pH 8 , pH 7, TEOS NPs 
in pH 7 aqueous solutions.
advantage of the degradation resistance at low pH value of ICPTES-sorbitol SiNPs in the 
application of oral-based drug carriers, since it will withstand the acidic environment in 
the stomach but degrade in the neutral to slightly acidic conditions.
The hydrolysis of the particles was also studied by IR spectrometry. 10 mg of 
ICPTES-sorbitol SiNPs were placed in 3 mL of aqueous HCl solutions for 1 week, and 
IR spectra of the supernatants were measured. As shown in the IR spectra, the 
supernatant of ICPTES-sorbitol SiNPs in pH 4 solution showed traces of the hydroxyl 
group vibration stemming from the release of sorbitol by the hydrolysis process. 
Meanwhile, there was no obvious sorbitol signal in the IR spectrum of ICPTES-sorbitol 
SiNPs supernatant obtained at pH 2. (Figure 4.15) The as-made ICPTES-sorbitol SiNPs 
and degraded ICPTES-sorbitol SiNPs were collected by centrifugation and measured 
gravimetrically. The weight losses of the as-synthesized ICPTES-sorbitol SiNPs, and the 
ICPTES-sorbitol SiNPs after incubation in the acidic solutions successively are shown in 
Table 4.6. The ICPTES-sorbitol SiNPs lost weight due to degradation; the particles 
degrade more in pH 4 solution compared to pH 2 solution.
In order to elucidate the degradation mechanism of the ICPTES-sorbitol SiNPs, 
the particles were redispersed in aqueous solutions for different time spans, and the 
morphology evolution during the degradation process was investigated by SEM and TEM. 
The ICPTES-sorbitol-2 sample degraded into irregularly shaped silica species under the 
acidic condition for 2 weeks. In contrast, the Stober SiNPs maintained their spherical 








































Figure 4.15. IR spectra of sorbitol, ICPTES, ICPTES-sorbitol SiNPs pH 4 supernatant 
and pH 2 supernatant.
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Figure 4.16. SEM images of a) ICPTES-sorbitol-2 SiNPs b) ICPTES-sorbitol-2 SiNPs 
in HCl solution for 2 weeks c) TEOS SiNPs d) TEOS SiNPs in HCl solution for 2 
weeks.
The degradation of ICPTES-sorbitol SiNPs was demonstrated by various 
characterization methods, but the diameter of the monodisperse spherical ICPTES- 
sorbitol-7 (referred as to ICPTES-sorbitol) SiNPs remained unchanged in aqueous 
solutions according to the SEM images (Figure 4.17). The SEM images revealed that the 
ICPTES-sorbitol SiNPs neither deformed into irregular shaped silica clusters, or shrunk 
their size in either acidic or neutral conditions.
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Figure 4.17. SEM images of ICPTES-sorbitol SiNPs a) in pH 4 solution for 1 days b) 
in pH 4 solution for 7 days c) in water for 1 days d) in water for 7 days.
Since SEM is restricted to the surface morphology detection, TEM (which is able 
to reveal the internal structure of the materials) was employed to study the transformation 
of ICPTES-sorbitol nanospheres due to the degradation. Figure 4.18 shows typical TEM 
images of ICPTES-sorbitol and Stober SiNPs after different degradation times in water. 
The TEM images showed that the as-made ICPTES-sorbitol SiNPs were solid with 
slightly rough surfaces, and became porous after immersion in water. Instead of 
degradation from the external surfaces, the spherical ICPTES-sorbitol SiNPs maintained 
their general appearances and uniform sizes, and degraded inside the spheres creating 
porosity. In contrast, the TEOS SiNPs retained their morphology and remained 
nonporous, even after a month of immersion in water. All the latter ICPTES-sorbitol 
SiNPs gradation experiments were done in water since the aforementioned measurement 
demonstrated that ICPTES-sorbitol hydrolysed in water, and the pure millipore water is a 
more simple medium in which to study compared to acidic solutions.
Quantitative study of the nanoparticle morphology was carried out by nitrogen 
sorption analysis. Figure 4.19 presents the nitrogen sorption isotherms for ICPTES- 
sorbitol particles before and after hydrolysis. The sorption isotherm of as-made ICPTES- 
sorbitol SiNPs exhibited a type II isotherm corresponding to a macroporous structure or a 
nonporous structure with rough surface. An additional capillarity condensation at the high 
relative pressure was caused by textural roughness. A type IV isotherm of ICPTES- 
sorbitol SiNPs verb (ending -ed) in water for a week indicated a mesoporous structure. 
There were two hysteresis loops in the isotherm of degraded ICPTES-sorbitol SiNPs. The 
hysteresis loop at lower relative pressure from 0.2 to 0.8 P/Po was attributed to the filling
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Figure 4.18. The TEM images of ICPTES-Sorbitol SiNPs in a) Ethanol; b) aqueous 
solution for 2 days; c) aqueous solution for 7 days; d) aqueous solution for a month e) 
TEOS SiNPs in water for a month.
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Figure 4.19. Sorption isothermals of ICPTES-sorbitol SiNPs before (red) and after 
(Blue) immersion in water for a week.
of the mesopores, and the broad range of the relative pressure where the loop was located 
indicating the wide distribution of the pore-size. The second hysteresis loop located at 0.9
P/Po was due to the interparticle aggregation. The Brunauer-Emmett-Teller (BET) surface
2 2area was 31.0 m /g and 266.5 m /g for ICPTES-sorbitol particle before and after the 
degradation, respectively. The hydrolysed particles displayed a broad distribution of pore 
sizes, which centred around 7.1 nm in diameter as determined by the BJH method.
The major silica dissolution product is monosilicic acid, which is nontoxic and 
can be transferred through the tissues, enter blood vessels, and eventually be excreted
30with urine. There are two quantitative methods that can be used to measure the amount 
of silicic acid. Inductively coupled plasma optical emission spectroscopy (ICP-OES) is
31used as a bulk analysis method to quantify the trace amounts of elements in solution. 
We measured the degradation rate of ICPETS-sorbitol using the alternatve, well- 
established molybdenum blue colorimetric method. The degradation product, Si(OH)4,
was detected by the reaction of molybdic acid with Si(OH)4, leading to yellow 
silicomolybdate. To increase the spectrophotometric sensitivity, the silicomolybdate was 
further reduced by hydrated ammonium iron sulfate to yield silicomolybdenum blue 
complex. This method has been used to detect trace concentrations of monosilicic acids
23 32 33by recording the UV-vis absorbance at 810 nm of silicomolybdenum blue complex. ’ ’
ICPTES-sorbitol SiNPs and SiNPs synthesized by Stober method were dispersed 
in millipore water. Aliquots of each suspension were taken out and centrifuged hourly for 
the first 5 h and then every 24 h. The supernatants were analyzed by the molybdenum 
blue method. Figure 4.20 shows that the degradation of ICPTES-sorbitol SiNPs was 
much faster compared to the Stober method particles, which almost did not dissolve in 
water. The fast degradation was not only due to the cleavage of carbamate groups, but 
also because of the higher surface area caused by the resulting porous structure, which 
increased the contact area between the silica and water. The ICPTES-sorbitol SiNP 
degradation proceeds by a fast bulk degradation within the first several hours followed by 
slower degradation, in agreement with other reports on the degradation behavior of 
mesoporous silica materials.31,34,35
Several reports describing the degradation behavior of mesoporous silica 
nanoparticles were published recently.34-39 The highly-ordered mesoporous structure was 
eventually destroyed in phosphate buffer or simulated human serum. Since our particles 
became porous during the degradation, we believe that the increasing porosity 
destabilizes the silica matrix. Figure 4.21 shows that some of the ICPTES-sorbitol SiNPs 
started to fall apart after the immersion in water for 2 months. This slow degradation 







Figure 4.20 Molybdenum blue tests result of ICPTES-sorbitol and TEOS SiNPs 
dissolution in milipore water.
Figure 4.21. SEM image of ICPTES-sorbitol SiNPs in aqueous solution for 3 months.
SiNPs were suspended in the same solution constantly. A faster degradation behavior 
would be observed if a flow system was used, continuously refreshing the solvent.
4.4 Conclusion
Our work aimed to address the limitation of in vivo silica nanoparticles 
applications due to their undesirable bioaccumulation by producing novel degradable 
SiNPs via the incorporation of organic groups. Bridged silsesquioxanes CME-APTES, 
ICPTES-EG and ICPTES-sorbitol were synthesized and used as silica precursors to 
produce nanoparticles. CME-APTES produced micro-sized SiNPs with degradability in 
acidic aqueous solution. SiNPs were produced from CME-APTES, ICPTES-EG and 
ICPTES-sorbitol by co-condensation with TEOS. Although CME-APTES, CME- 
APTES-TEOS and ICPTES-EG-TEOS SiNPs were degradable in acidic aqueous solution, 
their application was limited due to the sever agglomeration. Multiple analysis methods 
were used to characterize the ICPTES-Sorbitol SiNPs, and confirmed that the carbamate 
linkage of the precursor decomposed in aqueous solutions. Novel SiNPs, with water- 
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS
5.1 Conclusions
Design and synthesis of novel inorganic and organic/inorganic hybrid 
nanomaterials plays a crucial role in materials chemistry. In this thesis, we described the 
preparation of several new functional, inorganic and organic-inorganic hybrid 
nanoparticles, and characterized their properties with an eye on the potential bio-medical 
applications. Bio-compatible boron nanoparticles (BNPs) were produced by ligand 
exchange on fatty acid-covered boron nanoparticles. We demonstrated that the rigid 
bidentate diols replacing fatty acid on boron is a versatile ligand exchange strategy. The 
low cytotoxicity and easy cellular uptake make the prepared dopamine-coated BNPs 
(DA-BNPs) promising materials for Boron Neutron Capture Therapy (BNCT). Tannic 
Acid (TA) was used for the first time as a pore-directing agent to produce novel 
mesoporous silica nanoparticles (MSNs). The resulting particles possessed large pore size, 
unique pore structure, a narrow size distribution around 200  nm, and could immobilize 
proteins and enzymes. The tannic acid-templated mesoporous silica nanoparticles (TA- 
TEOS) may inspire the use of other nonsurfactant molecules as templates to produce 
MSNs. The study of protein immobilization suggested that electrostatic interaction and 
hydrogen bonding interaction are the important forces for protein adsorption on silica 
materials. The rate of protein adsorption on MSN is related to the sizes of the proteins:
the smaller the protein, the faster it reaches the adsorption saturation. The immobilization 
of the enzymes in TA-TEOS enhanced the thermal stability of the enzymes. Hybrid silica 
nanoparticles (SiNPs) were produced by incorporating hydrolysable silsesquioxanes into 
the silica matrix. The resulting particles showed different degradation behaviors 
depending on their composition. The ICPTES-sorbitol SiNPs displayed interesting 
degradation behavior, where the solid particles became porous after the hydrolysis. This 
project demonstrated the possibility of using bridged silsesquioxane with cleavable 
linkers to produce degradable SiNPs. It will inspire the preparation of novel SiNPs by 
bridged silsequioxanes with other cleavable linkers, such as the ones that respond to 
external stimuli.
Overall, this work described several strategies to produce novel boron and silica 
nanoparticles providing information about rationally designing nanoparticles for 
biomedical applications. It is of particular value for the fundamental studies of protein- 
silica interactions and silica material degradation behaviors.
5.2 Future directions
The long-term objective of the projects should be to explore the bio-medical 
applications of these novel NPs. This utility is governed by their toxicity. The in vitro 
study of the novel particles should be the next step. Although we obtained promising 
results in the preliminary study of DA-BNPs with the macrophage cell line, systematic in 
vitro studies of the particles, with varied concentrations and for various mammalian cell 
lines, are required to obtain a conclusive description of the BNPs behavior in vitro. This 
should be followed by cell targeting studies, both in vitro and in vivo using surface 
ligands, targeting receptors that are over-expressed on the cancer cells, such as folate
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1 2 3receptors, or antibodies selective for tumor-associated receptors. Targeting cancer 
cells with BNPs using the Enhanced Permeability and Retention (EPR) effect4 should be 
studied also.
Our studies of new mesoporous silica nanoparticles showed that, although the 
immobilization of Malic Dehydrogenase (MDH) in TA-TEOS increases the stability of 
the enzymes at room temperature, the immobilization did not enhance the catalysis 
activity of m-MDH. There are reports suggesting that the change of the enzyme 
conformation due to the incorporation inside mesopores enhances the activity of the 
enzymes.5 Thus, we should systematically study the influence of the pore size on the 
activity of the immobilized enzymes by encapsulation of MDH in TA-TEOS with 
different pore diameters.
Surface characteristics are important for the adsorption of proteins. Lei et al. 
showed that a higher amount of protein could be adsorbed, and protein stability was 
enhanced by choosing the optimal amount of functional groups on the surface of the 
mesopores. 6 Serra et al. showed that hydrophobic interactions between lipases and a 
methyl-functionalized surface preserved a higher catalytic activity of the adsorbed 
enzyme. We should modify the TA-TEOS with multiple functional groups, and study 
the adsorption of the proteins and the interactions between the proteins and functionalized 
silica particles.
The TA templated mesoporous SiNPs has many other potential applications, 
including chromatography, membrane separations and adsorbtion. Mesoporous silica 
particles might be good candidates for hydrogen storage materials due to their large 
surface area and pore volume. However, there are only a few reports on the application of
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MSNs for this purpose. Buckley et al. reported that MCM-41 at 77 K can reversibly 
absorb 1.6 wt% of hydrogen at 1.5 MPa. We tested the hydrogen storage ability of TA- 
TEOS at room temperature and under 1.5 MPa, but observed no hydrogen absorption. We 
may encapsulate palladium in the pores 9 by reducing the palladium ions to achieve 
hydrogen storage. Since TA-TEOS has disordered and interconnected pore morphology, 
they may trap palladium nanoparticles more efficiently compared to conventional MSN 
with 2D channels.
It will be interesting to explore the ability of other molecules with rigid structures 
and multiple hydroxyl groups to perform as a pore-directing agent to produce the MSNs.
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